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The Hedgehog signaling pathway is an evolutionarily conserved pathway that 
plays critical roles in both embryogenesis and adult tissue homeostasis.  It has been 
extensively studied in fruit fly, zebra fish and mouse models. Dysregulation of Hedgehog 
signaling causes a wide range of birth defects, such as craniofacial defects, limb defects, 
and holoprosencephaly. Ectopic activation of Hedgehog signaling in adult tissues also 
gives rise to tumors, such as basal cell carcinoma in the skin and certain types of brain 
cancers.  
Precise control of gene transcription is regulated by both genomic cis-regulatory 
elements as well as protein co-factors. To understand how Hedgehog signaling mediates 
transcriptional regulation, I investigated both genomic cis-regulatory elements as well as 
protein co-factors. Using mouse genetic approaches, I characterized a GLI responsive cis-
regulatory module, GRE1, and its role in Gremlin transcription regulation during limb 
development. I demonstrate that temporal and spatial controls of key developmental 
genes are mediated through comprehensive co-regulation of multiple cis-regulatory 
modules. In the second part of my study, I purified a GLI protein complex from 
embryonic stem (ES) cells and identified NANOG as a novel GLI-associated protein co-
factor in ES cells. Further studies revealed that NANOG inhibits Hedgehog signaling-
 vii 
mediated transcription by interfering with GLI activities, providing a new mechanism of 
how NANOG protects ES cells from extracellular differentiation signals. I also applied 
and optimized the affinity-purification and mass spectrometry technique to small 
embryonic tissue samples, which would allow us to identify protein complexes in more 
relevant context.  
 
 viii 
Table of Contents 
List of Tables ...........................................................................................................x 
List of Figures ........................................................................................................ xi	  
Chapter 1: Introduction ............................................................................................1	  
1.1 Hedgehog signaling pathway transduction ...............................................1 
1.2 Role of primary cilia in Hedgehog signaling ............................................2 
1.3 Sonic Hedgehog signaling in vertebrate limb development .....................3 
1.3.1 ZPA-Shh signaling ...............................................................3	  
1.3.2 Shh-FGF feedback loop .......................................................4	  
1.4 Gremlin in limb development ...................................................................6 
1.5 GLI binding regions and cis-regulatory modules .....................................6 
1.6 GLI-interacting proteins ............................................................................8 
1.7 Hedgehog signaling in stem cells and cancer .........................................11 
1.8 Summary .................................................................................................12 
Chapter 2: Characterization of GLI-responsive cis-regulatory modele GRE1 ......14 
2.1 Indentification of GLI responsive element 1 (GRE1) .............................14 
2.2 GRE1 enhancer activity requires Shh signaling .....................................15 
2.3 GRE1 enhancer domain is regulated by GLI activation .........................17 
2.4 GRE1 enhancer activity required sustained GLI activation ...................20 
2.5 GLI repression of the CRM prevents ectopic anterior expression of Gremlin
..............................................................................................................24 
2.6 The GRE1 CRM dunctions as a GLI-mediated silencer .........................25 
2.7 Discussion ...............................................................................................30 
2.7.1 GLI enhancer activity ........................................................31	  
2.7.2 GLI repressor activity ........................................................33 
2.7.3 GLI proteins generate asymmetric gene expression ..........34 
2.7.4 Multiple CRMs regulate Gremlin ......................................35 
2.7.5 Redundant GLI imput as a mechanism for fostering robust  
transcriptional control ........................................................37 
 ix 
Chapter 3: NANOG binds to GLI proteins in ES cells and represses Hedgehog 
signaling mediated transcription ...................................................................43 
3.1 NANOG binds to GLI1 in ES cells .........................................................44 
3.2 NANOG interacts with both GLI activators and GLI repressors ...........47 
3.3 NANOG represses GLI1-mediated transcriptional activation ................47 
3.4 NANOG binds to GLI1 through its C-terminal domains........................49 
3.5 The N-terminus of NANOG is essential for repressing GLI1-mediated 
transcription .........................................................................................51 
3.6 Hedgehog signaling upregulates NANOG protein levels in differentiation 
ES cells .................................................................................................52 
3.7 NANOG represses GLI1-meidated transcription in differentiating ES cells
..............................................................................................................52 
3.8 Discussion ...............................................................................................54 
Chapter 4: Future direction ....................................................................................59 
4.1 Explore GLI-NANOG interaction in adult stem cells ............................59 
4.2 Mass spectrometry anaylysis of GLI protein complexes in developing limb 
buds ......................................................................................................61 
Chapter 5: Materials and Methods .........................................................................62 
5.1 Generation of mouse strains ....................................................................62 
5.2 Embryonic manipulation .........................................................................64 
5.3 Statistics ..................................................................................................65 
5.4 Quantitative RT-PCR ..............................................................................65 
5.5 Tissue culture and cell lines ....................................................................66 
5.6 shRNA lentivirus infection .....................................................................67 
5.7 Immunoprecipitation and mass spectrometry .........................................67 
5.8 Western Blots ..........................................................................................68 






List of Tables 
Table 3.1:	  GLI3-interacting proteins identified by mass spectrometry .................45 	  
 xi 
List of Figures 
Figure 2.1: GRE1 enhancer acitvity correlates temporally with Shh activity in mouse
...........................................................................................................16 
Figure 2.2: GRE1 enhancer acitvity requires GLI activation ................................18 
Figure 2.3: Gli1 is significantly reduced in Gli3-/- forelimb ...................................19 
Figure 2.4: GRE1 enhancer acitvity in various genetic backgrounds at E11 ........20 
Figure 2.5: GRE1 enhancer acitvity requires sustained Shh signaling ..................21 
Figure 2.6: GRE1 enhancer activity is not negatively regulated by FGF ..............23 
Figure 2.7: GRE1 is necessary for GLI repression of Gremlin in the anterior limb 
buds ...................................................................................................24 
Figure 2.8: GRE1 is not essential for limb development .......................................26 
Figure 2.9 A single copy of the Gremlin with GRE1 is sufficient for limb 
development ......................................................................................27 
Figure 2.10 GRE1 interacts genetically with GLI3 to repress Gremlin ................28 
Figure 2.11 GLI proteins generate asymmetric expression of Gremlin .................36 
Figure 2.12 The GremlinΔGRE1 allele does not genetically interact with Shh ..........39 
Figure 2.13 Enahncer activities of GLI3 enriched regions located in Gremlin 
regulatory locus .................................................................................40 
Figure 2.14 The Gremlin regulation model ...........................................................41 
Figure 3.1 NANOG interacts with both GLI activator and repressor ....................46 
Figure 3.2 NANOG represses GLIA-mediated transcription activation ...............48 
Figure 3.3 Fucntion analysis of different NANOG domains .................................50 
Figure 3.4 NANOG represses Hedgehog signaling target genes in differentiating ES 
cells ...................................................................................................53 
 xii 
Figure 3.5 NANOG acts as in a negative feedback loop for HH signaling in ES cells
...........................................................................................................58 















Chapter 1:  Introduction 
The Hedgehog signaling pathway is an evolutionarily conserved pathway that 
plays critical roles in both embryogenesis and adult tissue homeostasis. It has been 
extensively studied in fruit fly, zebra fish and mouse models (reviewed in Ingham et al., 
2011). Dysregulation of Hedgehog signaling causes a wide range of birth defects, such as 
craniofacial defects, limb defects, and holoprosencephaly, while ectopic activation of 
Hedgehog signaling in adult tissues can also give rise to tumors, such as basal cell 
carcinoma in the skin and certain types of brain cancers (reviewed in Briscoe and 
Therond, 2013). 
 
1.1 HEDGEHOG SIGNALING TRANSDUCTION 
During embryogenesis, Hedgehog is expressed in different organizing centers of 
several embryonic tissues and acts as a long-range morphogen to control cell patterning 
and differentiation. The cellular signaling transduction of Hedgehog signaling pathway is 
initiated by the Hedgehog ligand binding to its receptor, Patched (Ptch), a cell-surface 
transmembrane protein that constitutively represses Hedgehog signaling. Upon Hedgehog 
binding, Ptch is no longer able to repress Smoothened (Smo), a member of the G protein-
coupled receptor (GPCR) superfamily. This de-repression causes a series of intracellular 
signaling cascades and eventually results in the activation of the downstream 
transcriptional effectors of the Hedgehog pathway.  
In Drosophila, Hedgehog signaling ultimately acts through Cubitus interruptus 
(Ci) on the transcriptional level. Ci is a bifunctional transcription factor that can act as 
either a transcription activator or transcription repressor. In vertebrates, Hedgehog 
signaling is mediated by the GLI transcription factors (GLI1, GLI2, and GLI3). GLI1 acts 
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only as a transcription activator, whereas GLI2 and GLI3 are bifunctional factors similar 
to the Drosophila Ci protein. In the absence of Hedgehog signaling, GLI2 and GLI3 are 
processed into transcription repressors while in the presence of Hedgehog, they are 
processed to be transcription activators. Gli1 is one of the Hedgehog direct target genes 
and requires Hedgehog signaling to be transcribed. GLI2 and GLI3 proteins are the first 
responders to Hedgehog signaling. After being processed into transcription activators 
upon Hedgehog signaling activation, GLI2 and GLI3 turn on the expression of GLI1, 
which acts as a signaling amplifier to the pathway (reviewed in Briscoe and Therond, 
2013).  
 
1.2 ROLE OF PRIMARY CILIA IN HEDGEHOG SIGNALING 
In vertebrates, the reception and initiation of Hedgehog signaling occurs in the 
primary cilium (reviewed in Goetz and Anderson, 2010). The receptor Ptch1 is found 
enriched in and around the primary cilium (Rohatgi et al., 2007). In the absence of 
Hedgehog signaling, GLI precursors are sequestered by SUFU at the base of cilia and 
further phosphorylated by PKA, CKI and Gsk3β. (Bariz et al., 2010; Fumoto et al., 2006; 
Tuson et al., 2011). This leads to proteolytic cleavage of the full-length of GLI precursors 
and the formation of GLI transcription repressors (GLI-R). Alternatively, in the presence 
of Hedgehog signaling, Ptch1 is removed from the primary cilia by unknown 
mechanisms, which causes the de-repression of Smo from Ptch1 repression (Kovacs et 
al., 2008). The resulting activation of Smo results in the dissociation of full-length GLI 
from SUFU and the transportation of GLI precursors from the cilia to the nucleus. After 
nuclear transport, GLI precursors are further phosphorylated by unknown kinase(s) to 
generate GLI transcription activators (GLI-A) (Humke et al., 2010). A recent study also 
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demonstrates that the phosphorylation levels of GLI proteins determine their activation 
levels. (Niewiadomski et al., 2014). This could partially explain how incremental changes 
in Hedgehog signaling are translated into gradient increments in transcriptional 
activation.  
 
1.3 SONIC HEDGEHOG SIGNALING IN VERTEBRATE LIMB DEVELOPMENT 
In vertebrates, there are three homologs of Hedgehog: Sonic Hedgehog (Shh), 
Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh). They all serve evolutionarily 
conserved roles in body organization (reviewed in Varjosalo and Taipale, 2008). Among 
them, Shh is the best-studied Hedgehog ligand and its functions in regulating organ 
patterning have been extensively explored in vertebrate limb development. During limb 
development, Shh plays essential roles in both limb outgrowth and digit patterning. Shh-/- 
mice lose all posterior structures in the autopod (distal limb) leaving only a single digit 
(digit 1) and the anterior part of zeugopod (Chiang et al., 2001; Kraus et al. 2001). In 
contrast, ectopic expression of Shh in the limb causes ectopic growth in the anterior-
posterior (AP) axis of the limb and results in the formation of polydactyly (Yang et al. 
1997). This suggests that Shh signaling directly regulates formation of the posterior limb 
elements, including digits 2 through 5, but not the anterior elements, such as digit 1. 
However, a recent study demonstrates that Shh signaling also contributes to the formation 
of anterior elements by negatively regulating Irx3 and Irx5 (Li et al., 2014a).    
 
1.3.1 ZPA-Shh signaling 
During limb development, Shh is expressed in the Zone of Polarizing Activity 
(ZPA), which is located in the posterior limb (reviewed in Zeller et al., 2009; Rabinowitz 
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and Vokes, 2012). Activation of Shh in the ZPA is regulated by a number of transcription 
factors. For example, Hand2 and 5’ Hox genes are required for Shh expression (Capellini 
et al., 2006; Trachini et al., 2006) and Tbx, Fgf8 and retinoic acid (RA) signaling are 
critical for restricting the Shh expression domain (Lewandoski, 2000; Niederreither et al., 
2002; Rallis et al., 2005). The resulting Shh expression pattern is a gradient with high 
expression in the posterior of limb and low expression in the anterior. This Shh protein 
gradient results in inverse GLI-A and GLI-R gradients along the AP axis, which controls 
the expression of distinct Shh target genes. Of the three GLI proteins, GLI3 is the 
predominant transcriptional repressor during limb development. Compared with Shh−/− 
embryos, Shh−/−;Gli3−/− embryos have a substantial rescue in limb growth and digit 
formation. The expression of many genes that are lost in Shh−/− limb buds are restored in 
Shh−/−; Gli3−/− embryos but with symmetrical gene expression patterns along the anterior-
posterior axis (reviewed in Rabinowitz and Vokes, 2012).  
 
1.3.2 Shh-FGF feedback loop 
The apical ectodermal ridge (AER) is another signaling center during limb 
development that controls proximal-distal (PD) axis limb outgrowth. It consists of a 
group of specialized epithelium located at the distal limb tip. The initiation of AER 
requires FGF10 signaling from the nascent limb mesenchyme. After AER initiation, 
FGF8 start being expressed in the AER progenitors and a growth-promoting positive 
feedback loop forms between AER-FGF8 and mesenchymal FGF10. Then Fgf4, Fgf9 
and Fgf19 are activated subsequently in the posterior AER (Lewandoski et al., 2000; 
Mariani et al., 2008; Sun et al., 2009). Removal of the AER results in severe limb 
truncations (Dudley et al. 2002; Rowe et al. 1982), and the application of FGF proteins to 
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limbs after AER has been removed can largely restore limbs outgrowth (Fallon et al., 
1994; Niswander et al., 1993).  However, of the four Fgf genes, Fgf8 plays the most 
important role during limb development as limb buds that lack Fgf8 are smaller and also 
lose certain skeletal elements (Lewandoski et al. 2000).  
Shh signaling and FGF signaling form a positive feedback loop in the developing 
limb. Shh signaling in the ZPA is maintained by FGF signaling from the AER, which is 
necessary for normal limb development (Laufer et al., 1994; Niswander et al., 1994). 
Depletion of FGF4 and FGF8 in the AER results in a loss of Shh expression in ZPA 
(Boulet et al. 2004; Sun et al. 2002). Meanwhile, Shh also maintains FGF signaling by 
inhibiting the activity of bone morphogenetic proteins (BMPs), which would otherwise 
disrupt AER integrity (Zuniga et al. 1999). Specifically, Shh represses BMP activity by 
upregulating Gremlin, a BMP antagonist protein. Gremlin is expressed in the limb 
mesenchyme between ZPA and AER, and relays the Shh signaling from the ZPA to the 
AER to reinforce the Shh-FGF positive feedback loop (Benazet et al., 2009; Nissim et al., 
2006; Panman et al. 2006; Zuniga et al., 1999).  
The termination of Shh-FGF feedback loop has been extensively studied in both 
chicken and mice models. Study in the chicken shows that the expansion of former Shh 
expressing cells in the limb eventually terminates the Shh-FGF feedback loop (Scherz et 
al. 2004). It is found that the Shh expressing cells and their descendents can’t express 
Gremlin. As the developing limb grows, the distance between the Gremlin expression 
domain and the ZPA increases, resulting in a breakdown of the Shh-FGF feedback loop. 
However, study in mouse reports that high levels of FGF can inhibit Gremlin expression 
(Verheyden and Sun, 2008). So the increasing FGF signaling from AER progressively 
increases the distance between Gremlin expression domain and AER. Eventually, 
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Gremlin no longer inhibits the BMP’s negative function on AER maintenance and Shh-
FGF feedback loop is no longer being maintained (Verheyden and Sun, 2008).  
 
1.4 GREMLIN IN LIMB DEVELOPMENT 
 Loss of Gremlin causes the formation of fewer digits because of the disruption 
of Shh-FGF feedback loop and the resulting up regulation of BMP levels (Benazet et al. 
2009; Khokha et al. 2003). In contrast, ectopic expression of Gremlin causes increased 
limb growth and the formation of extra digits (Scherz et al. 2004; Norrie et al. 2014). On 
the transcriptional level, Gremlin is induced by BMP signaling and then maintained by 
Shh signaling (Benazet et al., 2009; Capdevila et al. 1999; Nissim et al., 2006; Panman et 
al., 2006). The transcriptional regulation of Gremlin in the mouse limb bud is mediated 
the limb deformity locus and multiple long-range cis-regulatory modules were identified 
in this locus (Vokes et al., 2008; Zuniga et al., 2004; Zuniga et al. 2012). It has also been 
reported that Tbx2 directly represses Gremlin in the distal regions of the posterior limb 
mesenchyme (Farin et al, 2013). Loss of Tbx2 in the hindlimbs causes extended Shh and 
FGF signaling, resulting increased limb bud size and duplication of digit 4. Conversely, 
overexpression of Tbx2 leads to early local termination of Shh-FGF feedback loop, 
generating small limbs and fewer digits at posterior (Farin et al, 2013).   
 
1.5 GLI BINDING REGIONS AND CIS-REGULATORY MODULES 
On the genomic level, positive and negative regulations of transcriptional 
activities are mediated through cis-regulatory modules (CRMs), either enhancers or 
silencers, or both (reviewed in Noonan and McCallion, 2010; Ong and Corces, 2011). 
These regulatory regions are position and orientation independent, and they may be 
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located far from the specific gene locus. The precise mechanisms by which enhancers 
affect promoter activity are not well established, however, the predominant view is that 
enhancers are able to recruit transcriptional factors, forming a chromatin loop to bring 
enhancers and transcriptional factors to a specific promoter. For example, experiments 
examining Shh expression in the limb have shown that the long-range Shh enhancer ZRS 
physically interacts with the Shh transcriptional start site (Amano et al., 2009). 
Enhancers are thus those genomic elements that stimulate the gene transcription 
while repressors are able to repress the gene transcription. Recently, several studies 
reported that some essential genes are controlled by multiple-enhancers: the “shadow 
enhancers” (Frankel et al., 2010; Hobert 2010; Perry et al., 2010). In some cases, a single 
CRM contains both enhancers and repressors representing different signaling inputs 
(Murayama et al., 2004; Perissi et al., 2004). 
In vertebrates, Hedgehog ligands ultimately regulate transcription by controlling 
the activity of GLI transcription factors, which act as context-dependent transcription 
activators or repressors in response to Hedgehog signaling. Evidence from a number of 
studies indicates that all forms of GLI transcription factors can bind the same 9 base pair 
motif sequence (Hallikas et al., 2006; Muller and Basler, 2000; Peterson et al., 2012). The 
transcriptional output of GLI target genes is influenced both by the quality of the GLI 
motif sequence and the presence of tissue-specific co-factors. Studies in different 
organisms showed that Hedgehog responsive genes expressed near the source of 
Hedgehog signaling are associated with high quality GLI binding sites, while genes 
expressed at longer range are associated with lower quality GLI binding sites (Oosterveen 
et al., 2012; Parker et al., 2011; Peterson et al., 2012).  
In addition, the genomic regions surrounding GLI target genes often contain 
multiple GLI-binding regions, suggesting the possibility that multiple CRMs could 
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interact together to regulate gene expression (Biehs et al., 2010; Oosterveen et al., 2012; 
Peterson et al., 2012; Vokes et al., 2008). If these interactions exist, they could potentially 
result in redundant, synergistic, or dose-dependent regulation of target genes. 
GLI transcriptional targets fall into two distinct groups: genes that require GLI 
activation for transcription (GLI activator genes), and genes that are transcribed in the 
absence of GLI repression (GLI de-repression genes). GLI activators could potentially 
play quantitative roles in regulating the expression levels of a subset of this latter class. 
The behavior of target genes in response to a gradient of Hedgehog signaling suggests 
that competition between GLI activators and repressors could drive threshold responses 
that restrict the boundary of GLI-activator target gene expression (Jacob and Briscoe, 
2003; Ruiz i Altaba, 1997; Wang et al., 2000). Studies that have manipulated GLI 
expression levels in the chick neural tube support this competition model (Oosterveen et 
al., 2012). The mechanism by which GLI repression prevents expression of its target 
genes is poorly understood, but in some cases relies on interactions between GLI 
repressors and specific transcription factors (Oosterveen et al., 2012). Mouse neural 
tubes lacking the major GLI transcriptional repressor GLI3 have a relatively modest 
change in target gene expression boundaries with no change in ventral neural fates and 
more subtle changes to intermediate identities, an effect that could be due to the 
robustness of the neural-specific downstream regulatory network (Balaskas et al., 2012; 
Persson et al., 2002). 
 
1.6 GLI-INTERACTING PROTEINS 
In addition to looking for proteins involved in Hedgehog signaling transduction 
and GLI protein maturation, recent studies have started to elucidate the transcriptional co-
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factors involved in GLI transcriptional regulation. Ski was identified as a GLI3R-
interacting protein by a yeast two-hybrid screening using the N-terminal region of GLI2 
or GLI3 as bait (Dai et al., 2002). Ski and its related protein Sno act as transcription 
corepressors and are able to directly bind to two other corepressors, N-CoR/SMRt and 
mSin3A (Nomura et al., 1999). Together, these three corepressors form a protein 
complex with histone deacetylases (HDACs), which plays important roles in 
transcriptional repression. Ski was found to negatively regulate the Shh-induced 
activation of Gli1 through full-length GLI3 activators, and moreover, a Ski mutation in 
mice enhanced digit abnormalities caused by the Gli3 gene mutation. Another 
independent study published at the same year reported that mSin3 corepressor could be 
recruited by nuclear SUfU and results in the inhibition of GLI-mediated transcription 
(Cheng and Beachy, 2002). Consistently, these two studies suggest the corepressor-
HDACs complex is one of possible mechanisms underlying GLI-mediated transcriptional 
regulation.  
In addition to the HDAC corepressor complex, the members of the chromatin 
remodeling protein complex SWI/SNF have also been implicated in GLI-mediated 
transcriptional regulation, such as Snf5 and Brg (Jagani et al., 2010; Zhan et al., 2011). 
Snf5 was identified as a GLI1-interacting protein in an affinity purification-mass 
spectrometry experiment carried out on with mouse TM3 cells (Jagani et al., 2010). Snf5 
was found as a negative regulator of the Hedgehog pathway because the loss of Snf5 
leads to the activation of the Hedgehog-GLI pathway. Snf5 is also known as a tumor 
suppressor and biallelic inactivation was found in a majority of human malignant rhadoid 
tumors (MRTs), which are poorly differentiated cancers arising in the kidney, brain, liver 
and soft tissues (Biegel et al., 1999; Sevenet et al., 1999; Versteege et al., 1998). Re-
expression of Snf5 in MRT cell represses GLI1 activity and consistent with this, 
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Hedgehog-GLI target gene expressions were found in primary MRTs, suggesting a model 
that the tumor suppressor Snf5 represses Hedgehog signaling in adult tissue and loss of 
Snf5 causes ectopic activation of Hedgehog signaling and eventual tumorgenesis. A 
recent study reported that chromatin remodeling protein Brg can interact with GLI 
proteins and plays a dual role in regulating Hedgehog signaling during mouse neural 
development: it’s required for both repression of basal expression and for activation of 
signal-induced Shh target gene transcription (Zhan et al., 2012). Interestingly, Snf5 and 
Brg are both tumor suppressors as well as the core subunits of the SWI-SNF complex. 
These studies suggest that the Hedgehog pathway is likely to be the common target of the 
SWI-SNF complex and is also central to the tumor suppressor activity of Snf5 and Brg.   
Mediator is a large complex of proteins that serves as an interface between gene-
specific transcription factors and the RNA polymerase II general transcription machinery 
(Conaway et al., 2005; Kornberg, 2005). It has been proposed to function as a general 
conduit and integrator of regulatory signals and several Mediator subunits are required 
for transcription activation in response to distinct cellular signaling pathways (Boyer et 
al., 1999; Kato et al., 2002; Lau et al., 2003). GLI3 physically and functionally interacts 
with the Mediator subunit MED12 (Zhou et al., 2006). GLI3 is able to bind with MED12 
and Mediator/CBP complex through a transactivation domain MBD (MED12/Mediator-
binding domain). Disruption of the GLI3-MED12 interaction inhibits while MED 
depletion enhances both MBD transactivation activity and GLI3-dependent gene 
induction in response to Shh signaling.  
The phosphorylation state of GLI regulates its transcriptional activities. One of 
the possible reasons is that some phosphorylation sites affect GLI’s binding ability to it 
co-factors. 14-3-3 has been identified as a GLI negative regulator and is able to interact 
with all three GLI proteins (GLI1-3) through a phosphorylation dependent manner 
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(Asaoka et al., 2010). The 14-3-3 interaction with GLI causes repression of GLI 
activator’s transcription activity. More interestingly, the conserved phosphorylation site--
Ser640 for GLI1, Ser956 for GLI2 and Ser1006 for GLI3, is one of the PKA substrates 
on GLI proteins. PKA is one of the well-studied Hedgehog signaling negative regulators. 
One reported mechanism by which PKA influences Hedgehog signaling involves 
promoting the processing of the GLI precursor into repressor form (Chen et al., 1998; 
Wang et al., 2000; Pan et al., 2006). However, mediating 14-3-3 and GLI interaction may 
be a distinct PKA-dependent mechanism involved repressing Hedgehog signaling.      
 
1.7 HEDGEHOG SIGNALING IN STEM CELLS AND CANCER 
Because of its important roles in regulating early embryo development, 
dysregulation of Hedgehog signaling gives rise to a wide range of birth defects, including 
craniofacial defects, limb defects, and holoprosencephaly. Hedgehog signaling is also 
important for regulating homeostasis of adult tissues, including the epithelia of many 
internal organs and brain (reviewed in Jiang and Hui, 2008; Petrova and Joyner, 2014). 
For example, Hedgehog signaling is required for the regeneration of the pulmonary 
epithelium (Watkins et al., 2003), prostate epithelium (Karhadkar et al. 2004), and 
exocrine pancreas (Fendrich et al., 2008). Moreover, Hedgehog signaling plays a 
regulatory role in the formation and maintenance of adult hematopoietic stem cells 
(HSCs) in both Drosophila and zebrafish (Gering and Patient, 2005; Mandal et al., 2007), 
as well as in neural stem cells (NSCs) (Ahn and Joyner 2005; Balordi and Fishell, 2007; 
Dahmane et al., 2001; Lai et al., 2003; Machold et al., 2003; Palma et al., 2005; 
Wechsler-Reya and Scott, 1999) 
 12 
Ectopic activation of Hedgehog signaling in adult tissue gives rise to tumors. Gli1 
was initially identified because of its elevated expression in human glioma, a central 
nervous system tumor derived from the glial cells (Kinzler et al., 1987). Similarly, 
mutations in Hedgehog signaling pathway, including Ptch1 and Smo, and elevated level 
of Gli1 were also observed in basal cell carcinoma (Fan and Khavari, 1997; Ora et al., 
1997), and certain types of brain cancers (Hahn et al., 1996; Johnson et al., 1996; Taylor 
et al., 2002). It is widely assumed that the “GLI code” regulated by Hedgehog signaling 
is one of the reasons adult stem cells/progenitor cells turn into cancer stem cells (CSCs) 
(reviewed in Aberger and Ruiz i Altaba, 2014). Through the GLI code, Hedgehog 
signaling modulated the fate and normal behavior of stem cells. Recent studies also 
reported high expression levels of Nanog and Gli1 co-existed in different types of tumors 
and a NANOG-GLI positive feedback loop has been found in glioblastoma multiforme 
and medulloblastoma (Po et al. 2010; Zbinden et al. 2010). These results suggest that 
Hedgehog signaling could affect stem cells and progenitor cells bymodulating the 
pluripotent factor NANOG. 
 
1.8 SUMMARY 
To understand the basic mechanisms underlying Hedgehog signaling mediated 
transcriptional regulation, I conducted my PhD thesis work from two aspects. In the first 
part, my work focused on the long distance CRMs that regulate dynamic expression of 
Gremlin during limb development. By using a combination of mouse genetics and 
embryological manipulations, I characterized the first GLI-responsive CRM (termed 
GRE1, GLI responsive element 1) in vertebrates. I found GRE1 could act as both an 
enhancer and a silencer. As an enhancer, its activity requires sustained Hedgehog 
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activation; as a silencer, GRE1 prevents ectopic transcription of Gremlin driven through 
additional CRMs. In the second part of my thesis work, I searched for GLI co-factors in 
embryonic stem cells and embryonic limb buds. By applying affinity purification and 
mass spectrometry, I identified a number of potential GLI-interacting proteins from 
embryonic stem cells. I further explored the interactions between pluripotent factor 
NANOG and GLI proteins. My study suggests that NANOG represses Hedgehog 
signaling-mediated transcription by interfering with GLI transcription factors.
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Chapter 2:  Characterization of GLI-responsive cis-regulatory module 
GRE11 
The transcriptional response to the Hedgehog pathway is mediated by GLI 
proteins, which function as context-dependent transcriptional activators or repressors. 
However, the mechanism by which GLI proteins regulate their target genes is poorly 
understood. Here, we have performed the first genetic characterization of a GLI-
dependent cis-regulatory module (CRM), focusing on its regulation of Gremlin in the 
mammalian limb bud. The CRM, termed GRE1 (GLI responsive element 1) can act as 
both an enhancer and a silencer. The enhancer activity requires sustained Hedgehog 
signaling. As a GLI-dependent silencer, GRE1 prevents ectopic transcription of Gremlin 
driven through additional CRMs. In doing so, GRE1 works with additional GREs to 
robustly regulate Gremlin. We suggest that multiple GLI CRMs may be a general 
mechanism for mediating a robust transcriptional response to the Hedgehog pathway.  
 
2.1 IDENTIFICATION OF GLI RESPONSIVE ELEMENT 1 (GRE1) 
In a genome-wide chromatin immunoprecipitation study, we previously identified 
a 438-bp GLI3 binding region located over 100kb downstream of Gremlin that exhibited 
enhancer activity in transient transgenic limb buds in a region partially overlapping with 
Gremlin gene expression  (Fig 2.1A) (Vokes et al., 2008). Enhancer activity is 
dependent on the presence of at least one GLI motif as mutations of the motif resulted in 
                                                
1 This Chapter is adapted and modified from “Li Q, Lewandowski JP, Powell MB, Norrie JL, Cho 
SH, Vokes SA (2014). A Gli silencer is required for robust repression of gremlin in the vertebrate limb bud. 
Development 141:1906 -1914”. Limb culture assays were performed by Jordan Lewandowski, GRE1lacZ 
transgenic analysis was performed by Marian Powell, skeleton preparations were performed by Jacqueline 
Norrie, GRE1 BAC deletion was generated by Seung Hee Cho.  
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a complete lack of enhancer activity in G0 transgenic embryos (Vokes et al., 2008). We 
sought to characterize GLI enhancer regulation in the context of this CRM, which is 
henceforth referred to as GRE1 (GLI responsive element 1). Embryos derived from three 
founder lines of stable transgenics had β-galactosidase activity in posterior limb bud 
mesenchyme in an identical domain to that previously reported for transient transgenics 
(Vokes et al., 2008). We selected one line, Tg(Rr26-lacZ)438Svok, henceforth referred to 
as GRE1LacZ, for further analysis. β-galactosidase activity was first detected in embryos 
at E10.0 (31-32 somites; Fig 2.1B), well after the reported onset of Gremlin expression at 
~E9 (Benazet et al., 2009; Zúñiga and Zeller, 1999). The enhancer had activity in the 
posterior limb within a subregion of the Shh-responsive domain. Shh expression initiates 
in the limb bud around 28 somites (E9.75) (Charité et al., 2000), and the lag in reporter 
expression is consistent with the reported kinetics of Shh-mediated induction of Gremlin 
(Benazet et al., 2009).  By E10.5, β-galactosidase activity was strongly upregulated and 
persisted until late E11.5. By E11.75 expression was reduced and had retreated from the 
distal limb mesenchyme. Expression was nearly absent by E12.0 except for faint staining 
in the proximal middle of the condensing digit mesenchyme (Fig 2.1C-F). No expression 
was detected after E12.0, correlating with the termination of Shh activity in the limb 
(Echelard et al., 1993; Harfe et al., 2004). Although the enhancer analyses focused on 
forelimb expression, we observed similar domains in the hindlimbs (Fig 2.1G). 
 
2.2 GRE1 ENHANCER ACTIVITY REQUIRES SHH SIGNALING 
To determine if GRE1 is responsive to Shh signaling, we examined enhancer 
activity at E10.5 in Shh gain and loss-of-function backgrounds. In contrast to wild-type 




Figure 2.1 GRE1 enhancer activity correlates temporally with Shh activity in mouse 
A: Schematic showing the location of GRE1 in relation to the Gremlin locus and 
GRE1LacZ transgenic construct. B-G: GRE1LacZ+/- forelimbs from E10 to E12 (B-F) 
and hindlimb from E10.5 (G) embryos stained for β-galactosidase.  
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galactosidase activity (6/6 embryos) and, consistent with previous studies, Gremlin gene 
expression was highly downregulated (Fig 2.2B,B’)(Zúñiga and Zeller, 1999). We also 
examined expression by activating high levels of Hedgehog signaling throughout the 
limb bud using a Cre inducible dominant active allele, RosaSmoM2 (Jeong et al., 2004). 
Prx1Cre;RosaSmoM2c/+;GRE1LacZ+/- embryos expressed both the Gremlin transcript and β-
galactosidase activity throughout the entire distal limb bud (11/11 embryos; Fig 2.2C, 
C’), indicating that high levels of Hedgehog pathway activity were sufficient to activate 
GRE1LacZ along the anterior-posterior axis. Gremlin gene expression appeared patchy 
(Fig 2.2C’), and while the reason for this expression in unclear, it is consistent with 
observations from another study that also activated the Hedgehog pathway throughout the 
limb bud (Butterfield et al., 2009). Because PrxCre is active throughout the limb 
mesenchyme (Logan et al., 2002), the distal restriction of GRE1 enhancer activity 
suggested that additional, distal factors are also required for Gremlin expression. We 
concluded that Shh is both necessary and sufficient for enhancer activation. 
 
2.3 GRE1 ENHANCER DOMAIN IS REGULATED BY GLI ACTIVATION 
We next examined enhancer activity in Gli3-/-;GRE1LacZ+/- embryos at E10.5. 
Consistent with previous reports, Gremlin gene expression expands anteriorly in Gli3-/- 
embryos (Fig 2.2D’). In contrast the enhancer activity domain, marked by β-
galactosidase staining, does not expand anteriorly (Fig 2.2D). Instead, the domain is 
significantly reduced in all Gli3-/- embryos (5/5) compared to heterozygous littermates (p 
= 0.0007). The reduction in enhancer activity suggests a role for GLI3 activator in the 
posterior limb. Consistent with this, Gli3-/- limbs at this stage had significantly reduced 
levels of the GLI activator target gene Gli1 (Fig 2.3A). There was also a trend towards a  
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Figure 2.2 GRE1 enhancer activity requires GLI activation 
A-E’: E10.5 GRELacZ forelimbs indicating enhancer activity in various genetic 
backgrounds. The corresponding GLI gradient status (GLI activator in black, GLI 
repressor in red) is indicated to the right of each set of images. Embryos were dissected 
into halves; the left forelimb (left column) was stained for enhancer activity (β-
galactosidase) and the corresponding right forelimb(right column) was assayed for 
Gremlin gene expression. 
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Figure 2.3 Gli1 is significantly reduced in Gli3-/- forelimbs 
Data points indicate relative gene expression assayed by qRT-PCR for pairs of forelimbs 
from single embryos normalized to a single 32 somite wild-type sample for wild-type 
(n=6) and Gli3-/- littermates (n=5). All embryos were between 32-34 somites. A: The 
presence of an asterisk (red) indicates that Gli1 expression is significantly reduced in 
Gli3-/- forelimbs (Mann-Whitney U Test; U=1.000, p=0.0087). B: In the same sample, 
Shh levels tend to be reduced although not to statistically significant levels (Mann-
Whitney U Test; U=6.000, p=0.1255). The bars indicate the mean and standard error of 
mean. 
  
25% reduction in Shh levels that did not reach statistically significant levels (Fig 2.3B). 
These results are consistent with previous studies that have shown that Gli3-/- limb buds 
have reduced GLI activator levels as a combination of the direct reduction in GLI3 
activator and reduced levels of Shh (Bai et al., 2004; Galli et al., 2010; Wang et al., 
2007). 
In Shh-/-;Gli3-/-;GRE1LacZ+/- embryos, Gremlin expression persists in limb buds in 
a depolarized fashion as shown previously (Fig 2.2E’) (Aoto et al., 2002; Litingtung et 
al., 2002; te Welscher et al., 2002). However, the limb buds had an absence of β-
galactosidase staining (3/3 embryos; Fig 2.2E), indicating that GLI activation is required 
for GRE1 enhancer activity. This is consistent with our previous work that identified a 
GLI motif that was essential for driving enhancer activity (Vokes et al., 2008). Although 
we focused on enhancer activity at E10.5,  we noticed a single Shh-/-;Gli3-/-;GRE1LacZ+/-  
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Figure 2.4 GRE1 enhancer activity in various genetic backgrounds at E11 
GRE1LacZ+/- forelimbs stained for β-galactosidase activity. Limb buds in A,D,E,F are 
from embryos that were 40 somites, B from 38 somites, C from 42 somites. “a”, anterior; 
“p.”, posterior.  
 
embryo at E11 that had a thin stripe of β-galactosidase activity extending in a 
symmetrical arc across the distal limb bud (Fig 2.4E). A similar arc was seen in the 
anterior of E11 Gli3-/-;GRE1LacZ embryos while no activity was present in Shh-/- embryos 
(Fig 2.4). It is presently unclear whether this expression reflects a weak, late role for 
GLI3 repression in restricting the enhancer domain or some type of indirect activation 
(see Discussion). 
 
2.4 GRE1 ENHANCER ACTIVITY REQUIRED SUSTAINED GLI ACTIVATION 
To determine the time period during which GRE1 requires GLI-activator for 
enhancer activity, we used an established ex vivo limb bud culture assay, treating 
GRE1LacZ+/- limb buds with the Hedgehog pathway inhibitor cyclopamine (Panman et 
al., 2006). We cultured one forelimb in media containing cyclopamine while the 
contralateral side was cultured in control media, providing an internal control for staging 
and embryo variability (Fig 2.5B). As expected from the lack of activity in Shh-/- embryos 
(Fig 2.2B),  limb  buds  cultured in cyclopamine at stages before enhancer activity is  
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Figure 2.5 GRE1 enhancer activity requires sustained Shh signaling. 
GRE1LacZ+/- forelimbs were cultured in vehicle-containing control media (A-E) while 
their contralateral forelimbs were cultured in cyclopamine (A’-E’) as shown in (B). 
Graphs indicating the domain size measured by the ratio of the β-galactosidase stained 
area to the total limb bud area for control (black) or cyclopamine treated (red) limb buds. 
Data points indicate the median and range of values. The presence of an asterisk indicates 
statistically significant difference (Mann-Whitney U test). Specific values are: C’’ U=3.5, 
p =0.0004; D’’ U=1.5, p = 0.0065; E’’ U=7.5, p = 0.3333.  (F) Quantitative RT-PCR 
experiments from single forelimbs and their contralateral control limbs for representative 
31 and 38 somite embryos cultured in control and cyclopamine containing media (error 
bars indicate the standard error of mean). ‘a.’, anterior; ‘p.’, posterior.  
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detected (29-30 somites) resulted in a complete loss of β-galactosidase(Fig2.4A,A’). In 
limb buds cultured at 31-32 somites, there is a strong reduction (61%) in the size of the 
enhancer activity domain when compared to the control side (Fig 2.5C-C’’; p = 0.0004 ).  
Limbs cultured from 33-34 somites have more modest reductions (39%) in the size of the 
enhancer domain (Fig 2.5D-D’’; p =0.0065). The domain size no longer depends on Shh 
signaling from 35-36 somites onwards (Fig 2.5E-E’’; p = 0.3333). These results indicate 
that Shh signaling is required for expanding the domain of enhancer activity until 35-36 
somites. Since residual β-galactosidase protein could persist after the cessation of 
transcriptional activity from the reporter, it was not possible to determine if Shh is 
required to maintain enhancer activity with this approach. To circumvent this problem we 
performed additional limb bud cultures on 32 and 38 somite embryos and measured LacZ 
expression by qRT-PCR. As a control to ensure that the experimental conditions resulted 
in robust inhibition of Shh signaling, we measured the expression of obligate Shh target 
gene Gli1 (Panman et al., 2006). When forelimbs from 32 somite embryos were cultured, 
they had an 84% reduction in Gli1 gene expression and a 75% reduction in LacZ 
expression. Similarly, forelimbs cultured from 38 somites embryos had a 70% reduction 
in Gli1 and also had a 64% reduction in LacZ (Fig 2.5F).The change in gene expression 
at later stages contrasts with the stable expression domains indicated by β-galactosidase 
staining (Fig 2.5E-E’’). We concluded that establishing the enhancer domain requires 
Shh signaling transiently until 35 somites, while enhancer activity within the domain 
continues to require sustained Shh signaling.  
In addition to requiring Hedgehog signaling, GRE1 could potentially be 
negatively regulated by FGF signaling, which has previously been shown to negatively 




Figure 2.6 GRE1 enhancer activity is not negatively regulated by FGF 
E11.5 GRE1LacZ+/- forelimbs (45-48 somites) were cultured in vehicle-containing control 
media (0.1% DMSO) (A) while their contralateral forelimbs were cultured in 10uM 
SU5402 8 hours (B) and stained for β-galactosidase activity. The normalized distance of 
β-galactosidase domain from the distal (C) and anterior (D) limb (schematized as red 
lines in (A)) is not significantly altered in SU5402-treated embryos (Mann Whitney U 
Test). Horizontal lines indicate the mean and standard error. There is a reduction in the 
FGF target gene Sprouty4 in SU5402 cultured limb buds (H) compared to contralateral 
limb buds cultured in control media (G). A, B, G, H are from a 48 somite embryo; E, F 
are from a 45 somite embryo. 
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we cultured additional GRE1LacZ limb buds in the presence and absence of the FGF 
inhibitor SU5402 (Mohammadi et al., 1997). Consistent with previous results, Gremlin 
was expanded in the distal-anterior limbs in SU5402 treated cultures, but GRE1LacZ 
activity was not inhibited by FGF signaling (Fig 2.6). 
 
2.5 GLI REPRESSION OF THE CRM PREVENTS ECTOPIC ANTERIOR EXPRESSION OF 
GREMLIN 
To determine the effect of GRE1 on Gremlin expression, we examined G0 




Figure 2.7 GRE1 is necessary for GLI repression of Gremlin in the anterior limb buds 
A-C: BAC construct has lacZ inserted into the Gremlin coding region to act as a reporter 
of its transcriptional expression. Representative forelimb buds are shown from E11 G0 
transgenic embryos containing the indicated BAC construct. Gremlin expression from the 
unaltered BAC transgene is present exclusively in the posterior limb bud (A). Deletion of 
GRE1 (B) or mutation of the two GLI motifs present within GRE1 (C) results in ectopic 
distal-anterior expression. 
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which LacZ was inserted into the Gremlin coding region (Zuniga et al., 2004). Consistent 
with previous studies, β-galactosidase activity was restricted to the posterior limb in β- 
galactosidase-expressing embryos (0/6 have anterior expression; Fig 2.5A) (Zuniga et al., 
2004; Zuniga et al., 2012). The expression domain was similar although not identical to 
GRE1LacZ expression at the same stage (Fig 2.1D), and we hypothesized that deletion of 
GRE1 would reduce or eliminate reporter gene expression. Unexpectedly, the deletion 
resulted in ectopic anterior limb bud expression in most embryos (7/10; Fig 2.5B). The 
ectopic anterior expression suggested the presence of additional CRM(s) that either 
individually or collectively and have pan-limb enhancer activity. It also suggested that 
GRE1 is acting as a silencer in the anterior limb. We generated a third set of constructs in 
which GRE1 was re-inserted into the BAC with mutations in the two GLI DNA binding 
motifs present in the CRM (see methods). These forelimbs also contained ectopic anterior 
expression (3/3 embryos; Fig 2.5C). We concluded that GLI binding regions within 
GRE1 mediate silencer activity, preventing ectopic Gremlin transcription. This is 
consistent with the anterior expansion of Gremlin observed in Gli3 embryos (Fig 2.2D’). 
Synthesizing this result with the GRE1LacZ enhancer activity studies above, we conclude 
that GRE1 can act as both an enhancer in posterior limb and as a silencer that prevents 
ectopic anterior expression (see Discussion, Fig 2.11).  
  
2.6 THE GRE1 CRM FUNCTIONS AS A GLI-MEDIATED SILENCER 
The results described so far suggested that the GRE1 CRM likely mediates the 
transcriptional activity of Gremlin. We then generated mice containing a deletion of 
GRE1. GremlinΔGRE1/ΔGRE1 forelimbs expressed Gremlin and Formin at levels that are 
indistinguishable from wild-type control forelimbs (Fig 2.8A-C). GremlinΔGRE1/ΔGRE1 mice 
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were viable and fertile with normal skeletal patterning (Fig 2.8D-G). Embryos containing 
one null allele of Gremlin (Khokha et al., 2003) and a second allele harboring the 
deletion of GRE1 also had normal skeletal patterning (Fig 2.9). These results indicate that 
GRE1 is not necessary for normal skeletal development. The Gremlin gene expression 
domain was nearly normal in GremlinΔGRE1/ΔGRE1 embryos at E11 (Fig 2.8A,B) but at 
earlier stages, the distal anterior boundaries of expression were more diffuse (Fig 
2.8A,B). In light of these results, we hypothesized that redundant GLI - dependent CRMs  
 
 
Figure 2.8 GRE1 is not essential for limb development 
A, B: Gremlin expression in forelimbs at E11 (41 somites). C: Embryos express Gremlin 
and Formin at levels that are statistically indistinguishable from wild-type embryos (one 
sample t-test, two tails; Gremlin, P=0.1172; Formin, P=0.4548). Values are normalized to 
the distal marker jagged 1. Error bars represent the standard error of mean from four 
independent biological samples (E10.5, 34-37 somites). D-G: E18.5 skeletal preparations 





Figure 2.9 A single copy of the Gremlin with GRE1 is sufficient for limb development 
Embryos containing a null allele of Gremlin and the other allele with a deletion of CRM 
have normal limb skeletal patterning. Images depict forelimbs and hindlimbs from the 
same embryo at E18.5 stained for bone (Alizarin Red) and cartilage (Alcian Blue). The 
numbers of skeletons that were analyzed for each genotype are indicated below. 
 
might regulate Gremlin. Two additional GLI-binding regions are present within the 
Gremlin locus (Vokes et al., 2008). One of these regions was recently shown to have 
Shh-responsive enhancer activity and to be critical for mediating BAC reporter activity in 
transgenic embryos (Zuniga et al., 2012). We hypothesized that our GLI CRM might be 
redundant with other GLI-dependent CRMs under normal conditions but still required for 
robust regulation of Gremlin. 
Studies in Drosophila have tested the robustness of transcriptional responses to 
shadow enhancers by examining CRM deletion phenotypes at the outer ranges of 
permissive temperatures or by removing one copy of an upstream regulator (Frankel et al.  
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Figure 2.10 GRE1 interacts genetically with GLI3 to repress Gremlin 
A-H: Gremlin expression in various genetic backgrounds in the forelimbs of 35-36 
somite embryos (A-D) and hindlimbs of 37-38 somite embryos (E-H). The white brackets 
in panels (A,C) indicate the Gremlin free domain in anterior limb buds. White arrows 
(B,D,H) indicate ectopic distal-anterior Gremlin expression in Gremlin∆GRE1/∆GRE1 
backgrounds. (I-P) E18.5 skeletal preparations of the hand (J-L) or foot (M-P) in various 
genetic backgrounds. The arrowhead (K) highlights a bifurcated thumb; the asterisks 
(L,P) indicate polydactylous digits. (Q-T) Schematic models showing how Gli3 
repression of Gremlin might occur in various genetic backgrounds.  
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2010; Perry et al., 2010). We used the latter strategy to examine Gremlin expression in 
GremlinΔGRE1/ΔGRE1 embryos containing a single copy of Gli3, which is sufficient to 
prevent the distal-anterior expression of Gremlin seen in Gli3-/- embryos (te Welscher et 
al., 2002)(Fig 2.2D’). At E10.5, both wild-type and Gli3+/- littermates have a sharp 
boundary of Gremlin expression that is restricted from the most distal-anterior mesoderm 
in the forelimbs of all embryos (n=7; brackets in Fig 2.10A,C). GremlinΔGRE1/ΔGRE1 
littermates have forelimbs with less pronounced distal-anterior borders of Gremlin and 
with weak ectopic expression in the anterior limb mesoderm directly adjacent to the 
apical ectodermal ridge (n=10; dashed arrow in Fig 2.7B). In contrast, 
GremlinΔGRE1/ΔGRE1;Gli3+/- littermates have forelimbs with ectopic distal-anterior Gremlin 
expression that is broader and stronger than in GremlinΔGRE1/ΔGRE1 forelimbs (n=8; Fig 
2.10D). This expression is significantly different from Gli3+/- (p = 0.0002) or 
GremlinΔGRE1/ΔGRE1 forelimbs (p<0.0001), indicating a genetic interaction between GLI3 
and the GremlinΔGRE1 allele. 
An expansion of Gremlin protein into the anterior distal mesenchyme would 
inhibit BMPs, causing an expansion in anterior growth (Lopez-Rios et al., 2012; Pizette 
and Niswander, 1999). This growth would likely result in anterior polydactyly, which is 
also seen in mice with reduced BMP activity (Dunn et al., 1997; Selever et al., 2004). In 
the mixed genetic background present in our colony, the presence of the Gli3+/- ‘extra 
toes’ allele only rarely results in mice or embryos with fully polydactylous digits. In this 
study, all of the Gli3+/- embryos had a single nub (a fleshy outgrowth that sometimes 
contains a single speck of cartilage) but none of them had distinct polydactylous digits 
(18/18 hindlimbs; Fig 2.10O). GremlinΔGRE1/ΔGRE1 littermates have normal digit patterning 
(14/14 hindlimbs; Fig 2.10N). In contrast, GremlinΔGRE1/ΔGRE1;Gli3+/-littermates have a 
distinct, polydactylous digit in 3/8 hindlimbs (Fig 2.10P), a significant difference from 
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Gli3+/- embryos alone (p =0.0215). Gli3+/- forelimbs displayed a spectrum of phenotypes 
ranging from completely normal digits (7/17) to polysyndactyly (4/17). 
GremlinΔGRE1/ΔGRE1;Gli3+/- forelimbs uniformly contained a polysyndactylous thumb (8/8), 
a significant increase in frequency compared to Gli3+/-
 
embryos (p = 0.0005; Fig 2.10I-L). 
GremlinΔGRE1;Gli3+/- embryos also contained a high proportion of polysyndactylous 
forelimbs (23/28). These results suggest that GRE1 has silencer activity that is required 
for robust anterior repression of Gremlin. Our result is consistent with previous studies 
showing a genetic interaction between GLI3 and BMP4 (Dunn et al., 1997; Lopez-Rios et 
al., 2012). To determine if GRE1 might also be required to provide a GLI activator input 
for robust GLI enhancer activity, we performed a parallel analysis of compound crosses 
with Shh-/-
 
mice. GremlinΔGRE1/ΔGRE1;Shh+/- embryos have no genetic interaction, suggesting 
that the enhancer properties of GRE1 are either completely redundant or biologically 
irrelevant. We concluded that silencer activity through GRE1 is required for robust, GLI-
dependent repression of Gremlin in the anterior limb (schematized in Fig 2.10Q-T). 
 
2.7 DISCUSSION 
In this study we have performed the first genetic characterization of a vertebrate 
GLI CRM. Within the limb bud, most putative GLI target genes are associated with 
multiple GLI binding regions (Vokes et al., 2008). Our results suggest that one role for 
multiple, distinct GLI binding regions around GLI target genes is to provide a robust 
silencing response that buffers against genetic perturbations. This contrasts with the Fgf8 
and HoxD loci where multiple enhancers with similar activity domains have been 
proposed to additively or synergistically amplify transcription (Marinic et al., 2013; 
Montavon et al., 2011). Our results further suggest that GLI silencers prevent 
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transcriptional activity driven by additional, GLI-independent CRMs. We also show that 
GRE1 also has GLI-activator dependent enhancer activity in the posterior limb. Thus, the 
GRE1 CRM provides a platform for GLI activator and GLI repressor to respectively 
enhance or silence Gremlin expression. We propose a model where GLI repressors bind 
to multiple GLI-dependent CRMs in the anterior limb, providing a robust silencing 
activity that prevents ectopic activation of Gremlin that would otherwise be driven by at 
least one additional GLI-independent CRM that is active throughout the distal limb (a 
pan-limb enhancer). GLI repressor-mediated silencing results in the anterior repression of 
Gremlin in the absence of threshold levels of GLI activator complexes. In the posterior 
limb, where GLI activator activity is high and GLI repressor activity is low, GRE1 
silencing activity is lost and GLI-activator complexes provide enhancer activity. We have 
synthesized these results in a model for how Gremlin is regulated by GLI proteins within 
the limb (Fig 2.11). 
 
2.7.1 GLI ENHANCER ACTIVITY 
GRE1 enhancer activity is detected in the posterior limb in a spatial and temporal 
fashion that correlates with Shh signaling (Fig 2.1). GRE1 requires GLI-activation for 
initiating and sustaining activity at E10.5 and ectopic GLI activator signaling is sufficient 
to drive GRE1 expression throughout the anterior-posterior axis (Fig 2.2). These results 
suggest that GRE1 enhancer activity is primarily regulated by Shh signaling. GRE1 
enhancer activity is transiently reduced in E10.5 Gli3-/- limb buds (Fig 2.2D). Our own 
results (Fig 2.3) are consistent with several studies showing that Gli3-/- limbs have 
reduced levels of GLI activation caused by a combination of reduced levels of GLI 
proteins and a reduction in Shh (Bai et al., 2004; Bowers et al., 2012; Galli et al., 2010; 
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Wang et al., 2007). 
In marked contrast to Gremlin gene expression, the GRE1 enhancer domain does 
not expand in E10.5 Gli3-/- limb buds (Fig 2.2D,D’’). We rule out the trivial possibility 
that GLI repressors do not work through GRE1 because our subsequent experiments 
indicate that it does indeed mediate GLI repressor-mediated silencing of Gremlin (Figs 
2.7, 2.10) and it is bound by GLI3 repressor in chromatin immunoprecipitation assays 
(Vokes et al., 2008). The behavior of GRE1 contrasts with the behavior of a Dpp wing 
imaginal disc CRM in Drosophila, where both repressor and activator functions of Ci can 
be detected out in the same enhancer element (Muller and Basler, 2000). Within the 
mammalian neural tube, studies have reported conflicting conclusions regarding the role 
for GLI3 in restricting the boundaries of GLI activator enhancers or genes (Balaskas et 
al., 2012; Oosterveen et al., 2012; Peterson et al., 2012). 
In contrast to the absence of anterior expression at E10.5, there is a thin, anterior 
domain of enhancer activity at E11 in Gli3-/- and Shh-/-;Gli3-/- embryos. Previous 
experiments with G0 transgenics indicated that a GLI motif within GRE1 is absolutely 
required for enhancer activity at E11 (Vokes et al., 2008). It is presently unclear whether 
this expression reflects a weak, late role for GLI3 repression in restricting the enhancer 
domain, an artifact of the enhancer construct or transgenic line or some type of indirect 
activation. If this represents biological derepression, a possible model would be the 
presence of an unknown anterior activator in the anterior limb that is repressed by GLI3 
but activates late GRE1 activity. This would be consistent with our previous G0 
transgenic enhancer results because they were in wild-type limbs and so the hypothetical 
anterior activator would still be repressed (Vokes et al., 2008). 
There are several possible explanations for the lack of anterior expansion of 
GRE1LacZ in E10.5 Gli3-/-
 
limb buds. The first is that GLI repressors might not compete 
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with GLI activators to limit the anterior domain of enhancer activity. In this scenario, 
enhancer activity is driven solely by threshold-dependent GLI activation. The lack of 
baseline anterior activity would prevent visualization of the silencer activity in an 
enhancer reporter assay. A second possibility is that the GRE1LacZ transgenic construct 
is incapable of responding normally to GLI repressors because it is removed from its 
normal chromosomal environment. Indeed, our experiments suggest that GLI repressors 
do regulate the activity of additional CRMs in the Gremlin locus (Figs 2.10, 2.11). Taken 
out of context, GRE1 could also have altered affinities for GLI activator and repressor 
complexes that prevent its anterior expansion in Gli3-/- embryos. A third possibility is that 
residual GLI repressor activity is sufficient to prevent anterior expansion of GRE1LacZ in 
Gli3-/- limb buds. Consistent with this, recent work has indicated that there is a genetic 
role for GLI2 repressor in skeletal patterning in the absence of GLI3 (Bowers et al., 
2012). However, Gremlin expression appears largely symmetrical along the anterior-
posterior axis in Gli3-/- limb buds, suggesting that the remaining GLI repressor activity 
mediated by GLI2 might not be sufficient to repress Gremlin (Fig 2.2D’) (Aoto et al., 
2002; Litingtung et al., 2002; te Welscher et al., 2002). Additional studies examining 
GRE1LacZ enhancer activity in Gli2-/-; Gli3-/- limb buds would be necessary to determine 
if GRE1 itself is more sensitive to GLI2 repression than the overall Gremlin gene 
expression pattern would suggest. 
 
2.7.2 GLI REPRESSOR ACTIVITY 
Two models for GLI repression have been proposed. In one, GLI3 repressor acts 
as an inert decoy competing with GLI activator to regulate the transcription of target 
genes. In the second, GLI repressor behaves like a conventional transcriptional repressor, 
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recruiting transcriptional co-repressors that actively shut down transcription (Oosterveen 
et al., 2012; Wang et al., 2010). While the first model would apply specifically to GLI 
activator target genes, the second model could in principle apply to both GLI activator 
target genes and to genes that only require GLI derepression. GRE1 displays properties 
that are associated with both classes of GLI target genes. Gremlin is a GLI derepression 
gene and GLI3 works through GRE1 as a silencer, preventing transcription directed by 
additional CRMs that would otherwise lead to ectopic distal-anterior expression. In future 
studies, it will be interesting to determine mechanism of repression, which could function 
as a basal regulator of transcriptional activity. Alternatively GLI3 might specifically 
inactivate one or more CRMs. 
 
2.7.3 GLI PROTEINS GENERATE ASYMMETRIC GENE EXPRESSION 
In the posterior limb bud, it is unclear whether GLI activators are simply 
indicative of a de-repressed environment that permits additional CRMs to drive 
expression or if they also provide a quantitative contribution as enhancers to increase 
Gremlin transcription. The only evidence suggesting GRE1 is an enhancer is the 
enhancer activity of the isolated element in transgenic limb buds. While this fits the 
generally accepted criteria for an enhancer, there is no genetic evidence for reduced GLI 
activator responses in either GremlinΔGRE1/+or GremlinΔGRE1/ΔGRE1;Shh+/- embryos(Fig 2.12). 
There is also no observable reduction of posterior β-galactosidase activity in the BAC 
transgenics harboring a deletion in GRE1 (Fig 2.7B). The lack of any detectable 
phenotype suggests that in the context of the native genomic locus, the enhancer activity 
is absent, trivial or completely redundant with additional GLI-dependent CRMs. The 
ambiguity over the contribution of enhancer activity is represented in Fig 2.11, 
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suggesting that the major purpose of GRE1 enhancer activity lies in counteracting GLI 
repression rather than providing quantitative levels of activation. In this way, GRE1 
could act as a binary switch, causing transcription to be on or off in different domains. 
This model provides a mechanism for how Shh signaling imposes asymmetric expression 
of ‘pre-patterned’ genes that would, in the absence of any GLI regulation, be 
symmetrically expressed throughout the limb bud. It also suggests that the inclusion of 
GLI-driven CRMs into the locus of pre-patterned limb might have provided an 
evolutionary mechanism for regulating asymmetric gene expression in a pre-existing 
pattern. 
 
2.7.4 MULTIPLE CRMS REGULATE GREMLIN 
Within the context of this study, there appear to be at least three distinct CRMs 
regulating Gremlin. This is consistent with previous studies that describe a complex 
regulatory locus for Gremlin (Vokes et al., 2008; Wang et al., 1997; Zuniga et al., 2012; 
Zuniga et al., 2004). Several proteins have also been shown to regulate Gremlin at 
various developmental timepoints. In particular, BMPs and HoxA/D transcription factors 
both regulate Gremlin along the anterior-posterior axis. Their activity and expression 
domains make them excellent candidate regulators for the GLI-independent pan-limb 
enhancer (Fig 2.11) (Benazet et al., 2009; Capdevila et al., 1999; Nissim et al., 2006; 
Sheth et al., 2013). Intriguingly, HoxA/D conditional mutants lack most Gremlin 
expression with the exception of a posterior domain that appears nearly identical to the 
GLI CRM enhancer domain (Fig 2.1D) (Sheth et al., 2013). Although our model depicts 





Figure 2.11 GLI proteins generate asymmetric expression of Gremlin  
Gremlin is activated by a pan-limb enhancer (blue circle) that has activity throughout the 
distal limb. In genetic backgrounds in which there is an absence of GLI regulation (no 
activation or repression, e.g. Shh-/-;Gli3-/-), the pan-limb enhancer drives symmetrical 
expression of Gremlin throughout the limb bud. In the posterior region, GLI activators 
regulate redundant GLI-dependent CRMs, including GRE1, causing a loss of GLI-
mediated silencing and possibly threshold-dependent enhancer activity (indicated by 
dashed triangles). In the anterior region, GRE1 acts as a silencer, preventing ectopic 
activation of Gremlin through a pan-limb enhancer. The additional GLI-dependent 
CRM(s) could be either directly or indirectly regulated by Hedgehog signaling. 
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certainly possible that this activity integrates multiple GLI-independent enhancers active 
in distinct or overlapping domains. 
Recently, a second Gremlin CRM that lies closer to the transcriptional start site 
has been characterized. While it does not contain a high affinity GLI motif within the 
core region, it is nonetheless bound by GLI3 in ChIP assays and requires Shh expression 
for enhancer activity in mutant embryos (Zuniga et al., 2012). Unlike GRE1, the more 
proximal CRM is essential for Gremlin transcriptional activity in the same BAC reporter 
used in this study (Zuniga et al., 2012). Notably, GRE1 is not sufficient to activate 
transcriptional activity in its absence. This more proximal CRM could integrate GLI 
signaling with additional, Shh-independent, facets of Gremlin or there could be 
additional, uncharacterized GLI-dependent element(s). Our study was limited to the 
contribution of a single CRM, and future studies will be required to determine if there are 
higher-order chromatin interactions among the individual CRMs regulating Gremlin as 
has been suggested for the Fgf8 and HoxD loci (Marinic et al., 2013; Montavon et al., 
2011). In Drosophila, Ci repressors have been proposed to work cooperatively by binding 
to several distinct sites within a CRM regulating Dpp (Parker et al., 2011). The presence 
of an additional GLI CRM in the Gremlin locus raises the intriguing possibility that GLI 
proteins binding to distinct CRMs might nonetheless be able to cooperatively repress 
Gremlin in the context of a higher order chromatin structure. 
 
2.7.5 REDUNDANT GLI INPUT AS A MECHANISM FOR FOSTERING ROBUST 
TRANSCRIPTIONAL CONTROL 
Given the critical role for Shh in regulating Gremlin and the significant de-
repression observed when GRE1 was deleted in transgenic BAC reporters (Fig 2.4B), we 
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were initially surprised at the subtle phenotypes seen upon deleting the GLI CRM. 
Embryos and mice lacking GRE1 have no detectable skeletal phenotype. Nonetheless, 
embryos do have subtle shifts in Gremlin expression (Fig 2.6A,B), and when one copy of 
Gli3 is removed GRE1 is required for the repression of Gremlin. It is formally possible 
that the enhanced phenotype seen in GRE1;Gli3 compound heterozygous embryos (Fig 
2.6) is due to the presence of another allele co-segregating with GRE1. The primary 
support that this interaction occurs between GRE1 and Gli3 is that it is consistent with 
interactions observed between GLI3 and BMPs (which should have reduced anterior 
activity with ectopic Gremlin expression) (Dunn et al., 1997; Lopez-Rios et al., 2012). 
Both the subtle changes in expression pattern and the requirement of the CRM as a 
mechanism for buffering genetic variation are analogous to the shadow enhancers 
described in Drosophila (Barolo, 2012; Frankel et al., 2010). Shadow elements are 
defined by the genetic interactions of two genetically defined CRMs (Frankel, 2012) and 
further genetic studies involving multiple GLI bound elements would be required to 
determine if the GLI CRM is functioning as a shadow repressor of Gremlin. Our study, 
focused exclusively on a single GLI CRM, is the first to address the potential genetic role 
that multiple GLI-bound CRMs play in regulating transcription. Multiple GLI binding 
sites are associated with many predicted GLI target genes (Peterson et al., 2012; Vokes et 
al., 2008) and we propose that they may act as a general mechanism for mediating robust 
transcriptional responses to Hedgehog signaling. 
Gremlin is an important Shh target gene in limb buds. Its expression is absent in 
Shh-/- limb buds but rescued in Shh-/-;Gli3-/-. This suggests Gremlin is a Shh de-repression 
gene whose expression is driven by a Shh-independent enhancer, but suppressed by 
GLI3-mediated transcriptional repression. We previously identified three GLI3 ChIP 
enrichment peaks (Peak1-3) in the Gremlin regulatory locus. GRE1 (Peak1), one of the  
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Figure 2.12 The GremlinΔGRE1 allele does not genetically interact with Shh 
Gremlin ΔGRE1/+;Shh+/- males were crossed to Gremlin ΔGRE1/+ females and their litters were 
analyzed by skeletal preparations at E18.5 stained for bone (Alizarin Red) and cartilage 
(Alcian Blue). Representative hands from forelimbs are shown on the top row. The 
second row shows representative feet. The numbers of skeletons that were analyzed for 
each genotype are indicated below. All skeletal preparations were normal with the 
exception of a small, fleshy nub observed on one hindlimb of Gremlin ΔGRE1/ ΔGRE skeleton 
(something we have never otherwise observed). 
 
 
three peaks has been verified as a Shh-dependent CRM that acts as either an enhancer or 
repressor in a context-dependent fashion (Li et al. 2014b). I further test the potential roles 
of the other two GLI3 enriched regions in Gremlin regulation by G0 transient transgenic 
enhancer assays.  
 
To gain better understanding of the other two GLI enriched regions in the 
Gremlin regulatory locus (Zuniga et al. 2004), I cloned the two regions (indicated as 
“Peak2”, and “Peak3”, Fig 2.13) into a minimal-promoter LacZ reporter construct and 
tested in G0 transient transgenic for enhancer activity. Peak2 did not exhibit any enhancer 
activity in the embryonic limb buds (Fig 2.13C), however, Peak3 exhibited a strong pan-




Figure 2.13 Enhancer activities of GLI3 enriched regions located in Gremlin regulatory 
locus 
A: Schematic of minimal-promoter lacZ reporter. B: Schematic of the three GLI3 ChIP 
enrichment peaks. C: Peak2 has no enhancer activity in embryonic limb buds. D: Peak3 
acts as a pan-limb enhancer in our G0 transient transgenic test.  Peak3, but not Peak2, 
shows strong enhancer activity throughout the entire limb bud in G0 transgenic assay. 
Peak3::LacZ expression domain is much boarder than the Shh responsive domain, 
suggesting Peak3 might be a Shh-independent limb enhancer. 
 
gene expressing throughout the entire limb and the expression pattern extended into the 
proximal region where Gremlin gene expression normally does not existed.   
In order to test the silencer activity of GLI3 ChIP peaks, the 906bp human limb 
specific enhancer hs72(VISTA Enhancer Browser) was cloned into the minimal promoter  
LacZ reporter (hs72::LacZ) as control, and compared to reporters with Peak1 or Peak2 
sequence downstream of hs72, respectively (hs72_Peak1::LacZ and hs72_Peak2::LacZ). 





Figure 2.14 The Gremlin regulation model  
A: Schematic of testing silencer activity of Peak1 (GRE1) and Peak2. B: hs72 is a limb 
specific enhancer, and its expression pattern was limited at either anterior or posterior 
region by adding Peak1 or Peak2 respectively. C: Schematic of the “Gremlin regulation 
model”. In this model, Peak3 acts as a “Pan-limb enhancer”, and Peak1(GRE1) and 
Peak2 provide fine tuning of transcriptional regulation and maintain the normal Gremlin 
asymmetric expression pattern.      
 
 
throughout the entire limb bud, while Peak1 impaired LacZ expression at anterior and 
Peak2 repressed its expression in the posterior-distal region (Fig 2.14). 
Our genetic study of GRE1 (Peak1) suggests that Gremlin is likely to be repressed 
by multiple redundant CRMs; the observation from our lab that Gremlin expression is 
fully rescued in Shh-/-;Gli3-/- also suggests that Gremlin needs Shh signals for de-
repression but not activation. Thus, I propose a “Gremlin regulation model”:  during 
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limb development, Gremlin is driven by Peak3, an Shh-independent enhancer in the 
entire limb bud, but repressed by GLI3 through Peak1 and Peak2, two redundant cis-
regulatory modules that maintain the normal expression pattern. 
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Chapter 3: NANOG binds to GLI proteins in ES cells and represses 
Hedgehog signaling mediated transcription 
The Hedgehog pathway was initially characterized for regulating embryonic 
development but it also has critical roles in regulating the homeostasis of several adult 
tissues (reviewed in Petrova and Joyner, 2014). One of the best-characterized roles of 
Shh lies in its roles in regulating two major neural stem cell populations in the brain: the 
ventral sub-ventricular zone (VSVZ) and sub-germinal zone (SVZ). In the absence or 
inhibition of the Hedgehog pathway, both the VSVZ and the SVZ undergo a marked 
depletion in cells, indicating that the pathway is required for normal proliferation 
(reviewed in Alvarez-Buylla and Ihrie, 2014). Conversely, hyperactivation of the 
Hedgehog pathway results in an expanded population of neural stem cells. In this context, 
the progeny of neural stem cells is shifted so that they preferentially give rise to two 
daughter stem cells instead of producing transit amplifying cells capable of generating 
differentiated progeny (Ferent et al., 2014).  Together these results indicate that the 
levels of Hedgehog perceived by neural stem cells regulate the balance between 
generating stem cells and differentiated progenitors.  
In addition to regulating normal neural development, various studies have 
suggested populations of stem cells play key roles in medulloblastoma as well as 
glioblastoma (Po et al., 2010, Vanner et al., 2014). In glioblastoma cancer models, GLI 
proteins have been shown to activate the transcription of the pluripotency factor 
NANOG. NANOG in turn is critical for maintaining tumorigenic cell populations, 
suggesting a positive feedback between these factors (Po et al., 2010; Zbinden et al., 
2010).  
      While Hedgehog signaling via GLI transcription factors is critical for regulating 
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neural stem cells, the underlying transcriptional mechanisms remain poorly understood. 
In part, this is because it is difficult to isolate large numbers of these stem cells. In an 
effort to understand this process, we performed a mass-spectroscopy based screen to 
identify GLI binding proteins in mouse embryonic stem cells that might act as stem cell-
specific co-factors. Here, we report that GLI1 and GLI3 bind to the pluripotency factor 
NANOG. We find that the presence of NANOG inhibits GLI transcriptional responses in 
several different cell types. Interestingly, interactions between NANOG and GLI proteins 
have previously been implicated in regulating brain tumors (Po et al., 2010; Zbinden et 
al., 2010). Finally, we show that NANOG acts to dampen the response of ES cells to 
Hedgehog signaling. Previous studies have shown that NANOG also binds to and inhibits 
the BMP and NFκB pathways (Suzuki et al. 2006; Torres and Watt, 2008) in ES cells 
thus NANOG may play a more general role in insulating ES cells from the surrounding 
signaling environment.   
 
3.1 NANOG BINDS TO GLI3 IN ES CELLS 
To identify GLI associated proteins in stem cells, we utilized mouse embryonic 
stem (ES) cells. When cultured under the appropriate conditions, these cells remain 
pluripotent, allowing us to obtain large amounts of material. The ES cells contained a 
tamoxifen-inducible 3XFLAG-tagged Gli3 repressor (GLI3R) allele driven by the 
ubiquitous Rosa26 promoter, an allele that has previously been used to generate mice for 
chromatin immunoprecipitation experiments (ChIP) (Vokes et al., 2008). We performed 
anti-FLAG immunoprecipitation (IP) followed by mass spectrometry on lysates from 
tamoxifen-induced ES cells (expressing Flag-tagged GLI3R) and parental, control ES 
cells (not expressing Flag-tagged GLI3R).  We sorted the resulting list based on the  Z-  
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Table 3.1 GLI3R-interacting proteins identified by mass spectrometry 
Proteins identified in GLI3R protein complexes by mass spectrometry are sorted based on 
Z score with a cutoff value of 1.5.  Gray shade highlights the bait protein and two 
known GLI-interacting proteins. Green shade highlights the two pluripotency factors. 
*ES cell lysate background proteins (Wang et al. 2006) 
 
score enrichment (Lu et al. 2007) with a cutoff value of 1.5, resulting in 27 proteins. We 
then removed proteins that contained any spectral counts in control cells, resulting in a 
final list of 16 proteins (Table 3.1). The most enriched protein in this list was the bait 
protein, GLI3. This list contained two proteins, SUFU and 14-3-3, which have previously 
been shown to bind GLI proteins (Humke et al., 2010; Asaoka et al., 2010). The 
remaining 13 proteins have not previously been associated with GLI proteins. 
Interestingly NANOG, a well established pluripotency factor and its co-factor DAX-1 
(Wang et al., 2006)) were both present on this list and we decided to focus our 
subsequent efforts on characterizing this interaction.  
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Figure 3.1 NANOG interacts with both GLI activator and repressor 
A: Endogenous NANOG, but not OCT4, co-immunoprecipitated with both FLAG-tagged 
GLI activator (GLI1FLAG) and GLI repressor (GLI3RFLAG) in an anti-FLAG IP with 
GLI1FLAG and GLI3RFLAG expressing ES cell lines. B, C: Interactions between 
overexpressed GLI proteins and NANOG in NIH3T3 cells were verified by either anti-
FLAG immunoprecipitations (B) or anti-HA immunoprecipitation (C). Co-transfected 
GLI1/GLI3R and NANOG plasmids used in each experiment are indicated above the 
blots. The arrow labels a non-specific band. 
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To validate the interaction between GLI3R and NANOG, we performed additional 
immunoprecipitations(IP) by western blots (Fig 3.1A). NANOG is a core regulator of 
stem cells and acts in conjunction with SOX2 and OCT4 to maintain ES cell self-renewal 
and pluripotency (reviewed in Young 2011). However, OCT4 was not co-
immunoprecipitated with NANOG with GLI3R (Fig 3.1A). This suggests that the 
NANOG interacts with GLI3R in a complex that is distinct from NANOG::OCT4.  
 
3.2 NANOG INTERACTS WITH BOTH GLI ACTIVATORS AND GLI REPRESSORS 
The previous experiments demonstrated that NANOG binds to GLI3R. To 
determine if NANOG might also be able to interact with additional GLI proteins, we used 
an ES cell line containing a Cre-inducible, 3XFLAG-tagged full length Gli1 to perform 
additional immunoprecipitations. Unlike GLI2 and GLI3, GLI1 exists only as a full-
length protein where it acts as a transcriptional activator (reviewed in Hui and Angers, 
2011). As shown in Fig 3.1A, GLI1 binds to NANOG but not OCT4.  
To confirm that NANOG interacts with both GLI1 and GLI3R, we co-transfected 
NIH3T3 cells with constructs encoding HA-tagged NANOG and either 3XFLAG-tagged 
GLI1 or 3XFLAG-tagged GLI3R. Consistent with the previous interactions in ES cells, 
NANOG binds to both GLI1 and GLI3R (Fig 3.1B, C) 
 
3.3 NANONG REPRESSES GLI1-MEDIATED TRANSCRIPTIONAL ACTIVATION 
NANOG helps to maintain ES cell self-renewal and pluripotency in part by 
repressing key differential regulatory genes (reviewed in Young, 2011) To determine if 
NANOG influences GLI-mediated transcription, we first utilized a GLI responsive 
luciferase assay in NIH3T3 cells. Compared to cells transfected with GLI1 alone, cells  
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Figure 3.2 NANOG represses GLIA-mediated transcription activation  
A, B: GLI1-mediated Ptch-Luciferase activity was repressed by co-transfecting with 
indicated amounts of a NANOG expressing vector, in both NIH3T3 cells and P19 cells. 
Hedgehog signaling responsive Ptch-Luciferase reporter was co-transfected with 
indicated amount of GLI1 and NANOG expressing plasmids into NIH3T3 cells and 
luciferasae assay was performed as in described in Materials and Methods. C: RT Q-PCR 
of Hedgehog target genes Gli1 and Ptch1 in NIH3T3 cells upon purmorphamine (+HH) 
stimulation, in the absence and presence of ectopically expressing NANOG. Statistical 
significances were measured by a two-tailed, paired T-test from three independent 
experiments, *:P<0.05, ns: not significant, 0.1>P>0.05.    
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transfected with both GLI1 and NANOG had a dose dependent reduction in luciferase 
activity (Fig 3.2A). We noted a similar trend in the embryonic carcinoma P19 cells, 
where co-expression of NANOG reduced GLI1-mediated luciferase response (Fig 3.2B). 
To determine if NANOG expression also inhibited the expression of endogenous 
Hedgehog target genes, we treated NIH3T3 cells with or without purmorphamine, a small 
molecule that activates Hedgehog signaling (Sinha and Chen, 2006) and performed 
quantitative real time PCR (q-PCR) on cDNA. As expected, NIH3T3 cells treated with 
purmorphamine had increased expression of the Hedgehog target genes Ptch1 and Gli1 
compared to untreated cells (Fig 2C, D). When cells were transfected with NANOG, 
there is a significant 53% reduction in Gli1 (p=0.0482). Although not statistically 
significant (p=0.0524), there is a 35% reduction in Ptch1, suggesting a similar trend. 
 
3.4 NANOG BINDS TO GLI1 THROUGH ITS C-TERMINAL DOMAINS 
NANOG is a 305 amino acid protein contains a conserved homeodomain (95-
155aa) at the N-terminus and a tryptophan repeat (WR) domain (197-244aa) at the C-
terminus (Chambers et al., 2003; Mitsui et al., 2003). To identify the protein binding 
domain on NANOG, we generated a series of HA-tagged NANOG truncations (Fig 3.3A) 
and co-transfected them with FLAG-tagged-GLI1 (Fig 3.3B). As expected, full length 
NANOG was co-immunoprecipitated with GLI1. Constructs lacking the C-terminal half 
of NANOG did not interact with GLI1, indicating that the C-terminal half is essential for 
the interaction. To determine if the C-terminal region could bind NANOG, we generated 
additional constructs C1, C2 and C3 but were unable to obtain comparable expression 
levels to full-length NANOG and N1 most likely because of their small size (data not 
shown). To circumvent this, we generated additional fusion proteins containing a larger,  
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Figure 3.3 Function analysis of different NANOG domains 
(A).Schematic diagram of full-length NANOG and truncations that were tested in this 
study. HD: Homeodomain, WR: Tryptophan Repeat domain. (B),(C).Anti-FLAG 
immunoprecipitation with cell lysates from NIH3T3 cells co-transfected with FLAG-
tagged GLI1 and HA-tagged NANOG or truncations expressing vectors. (D).GLI1-
mediated Ptch::Luciferase activity was assayed in the presence of indicated Nanog 
truncations. Statistical significances were measured by a two-tailed, paired T-test from 
three independent experiments, *:P<0.05 
 
 51 
HA-YFP tag that resulted in comparable levels of expressions (Fig 3.3C). The C1 
truncation bound GLI1 at levels that were comparable to full-length NANOG (Fig 3.3C), 
suggesting that the C-terminal region of the NANOG is responsible for binding GLI1. 
We generated additional subdomains of the C-terminal half (C2, C3). The C2 construct 
bound only minimally to GLI1 the while C3 did not bind at all.  CD2 itself was not 
capable to bind GLI1. These results suggest that an extensive region of the C-terminal 
region of NANOG binds to GLI1. Interestingly, this C-terminal half of NANOG is also 
critical for interaction between NANONG and the NFκB family transcription factors 
(Torres and Watt, 2008), which suggests NANOG may contain a general motif that 
interacts with distinct transcription factors. 
 
3.5 THE N-TERMINUS OF NANOG IS ESSENTIAL FOR REPRESSING GLI1-MEDIATED 
TRANSCRIPTION 
The previous results indicated that the C-terminal region of NANOG (construct 
C1) is sufficient to bind GLI1. We next asked whether this region was also sufficient to 
inhibit GLI1-mediated transcription. To test this, we co-transfected GLI1 with specific 
NANOG truncation constructs and a GLI-responsive luciferase construct. Although C1 
robustly binds to GLI1, it does not repress GLI1-mediated transcription. As expected, 
GLI response was not reduced when the N-terminal region of NANOG (construct N1) 
was co-transfected with GLI1 (Fig 3.3D). The simplest interpretation of these results is 
that the N-terminus of NANOG inhibits GLI repression. This is consistent with other 
studies showing that the N-terminal portion of NANOG contains a transcriptional 
repressor motif (Chang et al., 2009)  
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3.6 HEDGEHOG SIGNALING UPREGULATES NANOG PROTEIN LEVELS IN 
DIFFERENTIATING ES CELLS 
In an effort to examine the significance of the NANOG-GLI interactions in ES 
cells, we activated Hedgehog signaling with the small molecule purmorphamine either 
under conditions that main stem cell growth or cause differentiation (by the withdrawal 
of Leukemia inhibitory factor, “-LIF”). In the presence of LIF, the expression of NANOG 
was highly expressed and unaffected by the stimulation of Hedgehog signaling (Fig 
3.4A). As expected, ES cells began differentiating upon LIF withdrawal and after 4 days 
expressed markedly lower levels of NANOG Interestingly, upon Hedgehog stimulation, 
NANOG levels were upregulated upon LIF withdrawal (Fig 3.4A) 
We next compared the ability of GLI to form complexes with NANOG in the 
presence and absence of Hedgehog signaling. Although NANOG was not upregulated by 
Hedgehog stimulation under normal conditions that maintained proliferation (Fig 3.4A), 
there was a marked increase in the amount of NANOG pulled down by GLI1 (Fig 3.4B). 
Because the GLI1 is a FLAG-tagged version under control of the Rosa26 promoter, this 
cannot be explained by a positive feedback response. Indeed, both Hedgehog-stimulated 
and unstimulated fractions contain comparable levels of GLI proteins. A similar 
enrichment of these complexes was noted in differentiating ES cells after LIF withdrawal 
(Fig 3.4B). This suggests that Hedgehog signaling promotes the formation of GLI1-
NANOG complexes in ES cells.  
 
3.7 NANOG REPRESSES GLI1-MEDIATED TRANSCRIPTION IN DIFFERENTIATING ES 
CELLS 
The previous experimental results suggested that NANOG acts as a transcriptional 




Figure 3.4 NANOG represses Hedgehog signaling target genes in differentiating ES cells 
A: NANOG protein level was upregulated by purmorphamine (+HH) treatment in the 
absence of LIF, but not in the presence of LIF. B: Anti-FLAG immunoprecipitations 
show significantly more NANOG protein binding to GLI1FLAG upon PM treatment. C, D: 
Induction of Gli1 and Ptch1 mRNA levels in response to PM treatments in the condition 
of Nanog knockdown.  RT Q-PCR analysis showed in the absence of LIF, that Gli1 and 
Ptch1 mRNA levels are upregulated 2-3 folds upon PM treatment, but not in the presence 
of LIF (compare “shCtrl-LIF” and “shCtrl+LIF”). Further knockdown of Nanog by 
lentiviral shRNA enhances the induction of Gli1 and Ptch1 in the absence of LIF 
(compare “shCtrl-LIF” and “shNG-LIF”), but not in the presence of LIF. Statistical 
significance was measured by a two-tailed, paired T-test from three independent 




that overexpressed NANOG. If NANOG represses GLI1-mediated transcription in ES 
cells, then reducing NANOG levels should elevate Hedgehog-mediated transcriptional 
responses. To test this, we infected ES cells with a lentiviral Nanog shRNA construct 
(shNG).  Under pluripotent conditions with LIF, shNG infection resulted in an average 
80% reduction in Nanog mRNA level (Fig 3.4C). As expected, Nanog levels are strongly  
downregulated upon LIF withdrawal, and were reduced a further 10% in shNG infected 
cells (Fig 3.4C). To determine if the reduced levels of NANOG levels affected 
Hedgehog-mediated transcription, we examined the expression of the pathway targets 
Gli1 and Ptch1, which are direct Hedgehog pathway transcriptional targets in a variety of 
different tissue types. Under normal ES cells conditions, we did not observe a difference 
in Gli1 or Ptch1 in Hedgehog stimulated cells. However, when ES cells were cultured 
under conditions where LIF was withdrawn, there were significant upregulations of Gli1 
(p=0.0282) and Ptch1 (p=0.0232) upon Hedgehog stimulation. Similarly, in shNG-
infected cells, there was no significant Hedgehog-mediated upregulation of Gli1 or Ptch1 
in the presence of LIF while upon LIF-withdrawal, Gli1 and Ptch1 were upregulated (Fig 
3.4D, E). These experiments indicated that ES cells that begin to differentiate become 
Hedgehog-responsive. Interestingly, shNG-infected cells had significantly stronger levels 
of Gli1-induction compared controls in the differentiating ES cells (p=0.036, Fig 3.4D). 
The levels of Ptch1, while elevated, were not significantly different than controls 
(p=0.1242, Fig 3.4E). Together, these results are consistent with a model where NANOG 
reduces Hedgehog responses by binding to and repressing GLI proteins.  
 
3.8 DISCUSSION 
In this study, we have identified a previously unknown protein-protein interaction 
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between NANOG and GLI proteins. We show that expression of NANOG inhibits the 
ability of GLI proteins to activate transcriptional reporters or endogenous target genes. 
This suggests that NANOG may repress the transcriptional activity of GLI proteins. 
Consistent with this, reduced levels of NANOG levels increases the level of 
transcriptional response to HH signaling in differentiating ES cells.  HH signaling also 
promotes the upregulation of NANOG, thereby generating a negative feedback loop. As 
NANOG is expressed in a variety of different stem cell populations, this interaction 
suggests a stem-cell-specific mechanism for dampening transcriptional responses to HH 
signaling.  
We used a mass-spectroscopy-based approach to identify proteins specifically 
enriched in cells expressing FLAG-tagged GLI3-R. In addition to identifying SUFU and 
14-3-3, previously characterized GLI binding proteins, we identified NANOG and its co-
factor DAX1 as well as approximately 20 other proteins. While this approach was clearly 
successful at identifying GLI-associated proteins, the proteins were detected at low 
levels. GLI3 (the bait protein), had an average of 85 spectral counts per experiment while 
most interacting proteins, including SUFU, 14-3-3, NANOG and DAX1 had only a few 
spectral counts per experiment and were not identified in all three experimental replicates 
(Table 1). Future strategies for improving the number of spectral counts would increase 
the signal and therefore improve the utility of this approach for identifying GLI co-
factors.  
While HH signaling has well-established roles in adult stem cell homeostasis, it is 
not clear if HH signaling is active in mouse ES cells. It is not essential for mouse ES cell 
survival and ES cells lacking the essential receptor SMOOTHENED are capable of 
contributing to a range of different tissues in chimeric mice (Wijgerde et al., 2002). For 
these reasons, the interactions we report may be more applicable to understanding HH-
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regulated transcription in adult stem cells. Interestingly, a GLI1-NANOG signaling has 
been described in an important positive feedback loop in neural stem cells.  In 
particular, GLI1 acts as a transcriptional activator of NANOG in glioma stem cells and 
cerebellar neurospheres (Po et al 2010; Zbinden et al., 2010). Consistent with this, we 
find that HH signaling upregulates NANOG protein in differentiating ES cells. It is 
possible that this occurs through transcriptional activation although the increased levels 
of Nanog were not statistically significant. Regardless of the mechanism, HH signaling 
ultimately causes increased amounts of NANOG protein, thereby acting as a positive 
regulator. Upregulated NANOG levels would then be able to form complexes with GLI-
A proteins that would inhibit subsequent GLI activation. In doing so, this is acting as a 
negative feedback loop (Fig 3.5).  
This negative feedback loop contrasts with the positive feedback loops by which 
GLI and NANOG have been proposed to function in human glioblastoma stem cells and 
cerebellar neurospheres (Po et al., 2010; Zbinden et al., 2010). A possible explanation for 
this apparent difference might be that NANOG does not appear to completely block HH 
signaling. It is possible that the upregulation of GLI signaling observed in these other 
systems might be indicative of reduced but still active levels of GLI transcription. The 
over-activation of HH signaling in neural stem cells by Ptch1 deletion results in reduced 
numbers of differentiated neuronal progeny and increased numbers of neuronal stem cells 
(Ferent et al., 2014). Since neuronal stem cells also require HH signaling to generate 
differentiated neuronal progeny (reviewed in Petrova and Joyner 2014), the levels of HH 
signaling perceived by neuronal stem cells must be tightly regulated to ensure a balance 
between stem cell renewal and differentiation. By regulating GLI levels, NANOG could 
provide another level of negative feedback to regulate the transcriptional response to HH 
signaling in ES cells.  
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Two different categories of models could explain how NANOG represses 
activation of GLI target genes. NANOG could sequester GLI proteins, preventing them 
from binding to their DNA target sequences. Alternatively, NANOG might associate with 
GLI proteins as they bind to DNA and subsequently recruit repressor proteins. We favor 
the latter class of models because the C-terminal region of NANOG robustly binds GLI1 
but does not inhibit GLI target gene activation (Fig 3.3A-C). Consistent with the ability 
to recruit repressors, NANOG has previously been shown to associate with several 
repressor complexes that also contain OCT4 (Liang et al., 2008). Because GLI proteins 
do not include OCT4 (Fig 3.1A), the NANOG::GLI1 complex could potentially include 
distinct as well as common repressors. One possible candidate for this complex is DAX1, 
which was also identified as a GLI3-interacting protein in the mass spectrometry dataset 
(Table 3.1). DAX1 is a transcriptional co-repressor in several contexts, including ES cells 
(Li et al., 2011; Uranishi et al., 2013; Sun et al 2009). Like NANOG, DAX1 is a core 
member of the ES cell pluripotency network and has previously been identified as factor 
binding NANOG (Kim et al., 2008; Wang et al., 2006; Zhang et al., 2014; Wang et al., 
2008; van den Berg et al., 2010). In addition to binding GLI1, NANOG also binds to a 
truncated, repressor-specific form of GLI3 (Fig 3.1). While assays for GLI transcriptional 
activation are straightforward, genetic approaches are currently the only meaningful way 
of determining loss of GLI-R without concomitant GLI activation. In future studies, it 
will be interesting to determine if NANOG binding also affects GLI-R activity. 
NANOG has previously been shown to interact with Smad1, a transcriptional 
mediator of BMP signaling. Similar to what we have shown in this study, NANOG binds 
to Smad1 and inhibits BMP-mediated responses that would normally drive ES cells to 
differentiate (Suzuki et al., 2006). NANOG has also been shown to prevent NFκB 
induced differentiation by binding to NFκB family transcription factors (Torres and Watt, 
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2008). Together with our results, these studies indicate a common mechanism by which 
NANOG inhibits transcription. Interestingly, the C-terminal half of NANOG that binds 
GLI proteins also mediates the interaction between NANOG and the NFκB family 
transcription factor REL-A (Torres and Watt, 2008). It remains to be determined if 
NANOG binds to these different proteins through an adapter protein or via direct 




Figure 3.5 NANOG acts as in a negative feedback loop for HH signaling in ES cells
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Chapter 4: Future directions 
 
4.1 EXPLORE GLI-NANOG INTERACTION IN ADULT STEM CELLS  
In Chapter 3, I uncovered the GLI-NANOG interaction in ES cells and further 
demonstrated that NANOG is able to repress GLI-mediated transcriptional activation. 
Many studies suggest that Shh also regulates adult tissue homeostasis through regulating 
adult stem cell populations within these tissues (reviewed in Alvarez-Buylla and Ihrie, 
2014; Beachy et al. 2004; Jiang and Hui, 2008; Petrova and Joyner, 2014). However, how 
Shh-mediated regulation occurs at molecular level in these adult stem cell populations is 
still unknown. One of the interesting future directions is to determine if the GLI-NANOG 
interaction also exists in adult stem cells and what is the biological significance of this 
interaction.  
Neural stem cells are quiescent stem cells mainly located in the subventricular 
zone (SVZ) of the lateral ventricle and in the subgranular zone (SGZ) of the hippocampal 
dentate gyrus (reviewed in Fuentealba et al. 2012). During neurogenesis, NSCs give rise 
to short-lived transit-amplifying cells to generate new neurons in the adult brain. 
Hedgehog signaling has extensive roles in the regulation of this process (reviewed in 
Petrova and Joyner, 2014; Traiffort et al. 2010). Shh signaling is required for the 
establishment of the NSCs in both the SVZ and SGZ (Balordi and Fishell, 2007; Han et 
al. 2008). Once the SVZ and SGZ are formed, Shh signaling is continuously required for 
their maintenance (Ahn and Joyner, 2005). During this process, Shh signaling need be 
maintained at proper level: gain or loss of Shh signaling enhances or inhibits proliferation 
of NSCs, respectively (reviewed in Petrova and Joyner, 2014). However, the mechanisms 
of maintaining the appropriate Shh signaling level in NSCs during neurogenesis are still 
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unknown. In NSCs, Hedgehog signaling directly activates Nanog transcription (Po et al. 
2010), and as I showed in Chapter 3, NANOG is able to represses Hedgehog signaling by 
interfering with GLI proteins. These results leads to the hypothesis that Hedgehog 
signaling and NANOG form a self-regulatory feedback loop in NSCs to maintain correct 
level of Hedgehog signaling during neurogenesis. In future experiments, this could be 
addressed using following strategy. 
First, does GLI1 physically interacts NANOG in NSCs? This could be addresses 
by using FACS sorting to purify both NANOG positive NSCs and NANOG negative 
NSCs from SVZ, and determine if Shh target genes are highly expressing compared to 
NANOG negative NSCs. I will use immunostaining to determine if GLI and NANOG 
proteins are co-localized in NSCs and use co-immunoprecipitation to verify the GLI-
NANOG physical interactions. 
Second, does NANOG repress Shh target genes in NSCs? In Chapter 3, I showed 
that NANOG represses GLI-mediated transcriptional activation to inhibit Shh-induced 
differentiation. This could be addressed by performing a tissue-specific knockout of 
Nanog in NSCs. If the transcriptions of Shh target genes such as GLI1 is altered due to 
decrease of NANOG, follow up studies could then use NANOG ChIP to determine if the 
changes of transcriptions of Shh target genes are directly due to loss of NANOG at 
promoter/enhancer regions of those genes. Finally, this could be addressed by testing Shh 
gain or loss of function in the presence and absence of NANOG in NSCs, to determine if 




4.2 MASS SPECTROMETRY ANALYSIS OF GLI PROTEIN COMPLEXES DURING LIMB 
DEVELOPMENT 
The function of GLI has been extensively studied as its key role in the Shh 
signaling pathway. However, aside from neural-specific SoxB1 proteins (Oosterveen et 
al., 2012; Peterson et al., 2012), little is known about the tissue-specific transcriptional 
co-factors involved in GLI-mediated regulations at different embryonic tissues. Previous 
studies attempting to identify GLI associated co-factors were conducted with established 
stable cell lines that express epitope-tagged GLI (Asaoka et al., 2010; Jagani et al., 2010). 
Considering the tissue specification and organ patterning directed by Shh signaling is a 
very complicated process that involves proliferation and differentiation of different types 
of cells, the generic GLI-repressor complex might not exist in those highly specified 
homogeneous cell lines. To circumvent this, it is ideal to purify GLI protein complexes 
from embryonic tissues where Shh plays important regulatory roles.  
Affinity purification and mass spectrometry are widely used approaches to 
identify new protein co-factors in existent protein complexes. However, there are no 
publications describing their successful applications in embryonic tissues. Two 
conditional mouse lines harboring FLAG-GLI1 and FLAG-GLI3R were previously 
established by our lab and successfully used for GLI ChIPs within embryonic tissues 
(Vokes et al. 2007, 2008). To identify the GLI co-factors in more relevant contexts, I 
propose crossing the conditional FLAG-GLI1 and FLAG-GLI3R lines with PrxCre line 
to specifically express FLAG-tagged GLI activator (GLI1) and repressor (GLI3R) in the 
limb buds respectively. This will allow us to study both GLI activator and repressor 
complexes systematically in embryonic limb buds. 
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Chapter 5:  Materials and Methods 
Experiments involving mice were approved by the Institutional Animal Care and 
Use Committee at the University of Texas at Austin). The compound crosses of mice 
used to determine genetic interactions were compared with littermate controls. The 
genomic coordinates in this study are reported in the mm10 build 38 genomic assembly. 
 
5.1 GENERATION OF MOUSE STRAINS 
The GRE1LacZ transgenic line, officially named Tg(Rr26-lacZ)438Svok 
(MGI:5052053), was generated by pronuclear injection using the previously described 
enhancer reporter construct containing the 438-bp GLI binding region (chr2:113640843-
113641280) (Vokes et al., 2008). The BAC transgenic constructs were generated using 
the Quick&Easy BAC Modification Kit (Gene Bridges) to modify a previously generated 
BAC containing LacZ within the Gremlin transcript (Zuniga et al., 2004). The homology 
arms for both targeting vectors were chr2:113,640,295-113,640,842 and 
chr2:113,641,281-113,641,757. After targeting, the FRT-flanked neomycin- resistance 
cassette was removed with a heat shock inducible FlpE construct (Gene Bridges), leaving 
a 69-bp FRT site and linker sequence precisely in place of the GLI CRM 
(chr2113640843-113641280). The GLI binding sites within the CRM were mutated from 
TAGGTGGTC (chr2:113641085-113641088) to TACCACGTC and CACCTCCCA 
(chr2:113641174-113641177) to CACGTGGCA; the mutated CRM was flanked by a 
5’EcoR1 site and a 3’ 70bp linker sequence that included the FRT site. The official name 
for the  GremlinGRE1  allele is Rr26<tm1Svok>  (MGI:5486166).  This allele results in 
the replacement of the438-bp CRM sequence with an 89-bp sequence containing a single 
LoxP scar. A 7.5kb genomic fragment containing the Gremlin CRM ( chr2:113,637,382-  
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Figure 5.1 Generation of mice with a deletion of GRE1 
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113,644,893) was digested from BAC #RP23-113H17 with Xma1 and Kpn1 and cloned 
into a pBluescript upstream of a diphtheria toxin A (DTA) negative selection cassette 
(Fig 5.1A). A single loxP site and then an FRT-Neo-FRT-LoxP cassette were inserted 
immediately upstream and downstream, respectively, of the CRM (chr2:113640843-
113641280). The targeting vector was linearized with KpnI and electroporated into AV3 
ES cells (obtained from Dr. Andy McMahon’s laboratory). Approximately 200 colonies 
were screened by Southern blot. DNA was digested with Bgl I and hybridized with a 5’ 
probe corresponding to chr2:113636128-113636494 and a 3’ probe corresponding mm10| 
chr2:113,648,199- 113,648,558. We identified two correctly targeted colonies by 
Southern blot, which were used to generate chimeric mice. Germline-transmitting 
chimeras were crossed with a Cre deleting strain, Sox2Cre, to generate a deletion allele, 
GremlinΔGRE1
 
(MGI:5486166). Mice that were wild- type, heterozygous and homozygous 
null mice were determined by genotyping with primers flanking the CRM (indicated by 
arrows underneath targeting constructs) that amplify a 582bp fragment in the wild-type 
allele and a 210bp fragment in the deletion allele (Fig 5.1B). The sequences of the 
primers are: 5’-GCTAAACACAAAGAACTTTTAATGG-3’ and 5’- GCAGCAGCAGT 
A TTTTTCAGA-3’. 
 
5.2 EMBRYONIC MANIPULATION 
When applicable, limbs were cultured for 15 hours in 10 M Cyclopamine 
dissolved in absolute ethanol (Toronto Research) or 0.125% absolute ethanol for controls. 
After incubation, limb buds were separated from adjacent tissues and processed for qRT-
PCR, β-galactosidase staining, or in situ hybridization. All limb buds were assayed for β-
galactosidase activity by staining overnight using established methods (Whiting et al., 
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1991). Skeletal preparations were performed as described previously (Allen et al., 2011). 
 
5.3 STATISTICS 
Unless indicated otherwise, in Chapter 2, statistical significance was measured 
using Fisher’s Exact Test with a two-tailed P-value. In Chapter 3, statistical significance 
was measured using paired T-test with a two-tailed P-value, from three independent 
experiments was used.    
 
5.4 QUANTITATIVE RT-PCR 
RNA was extracted from a single pair of E10.5 embryonic limb buds (Chapter 2), 
or different cell lines (Chapter 3) using the RNA-Aqueous 4-PCR kit (Ambion) and 
subsequently treated with DNAse1. cDNA was synthesized from 300ng of total RNA 
with random hexamers using SuperScript II (Invitrogen). qRT-PCR experiments were 
performed using Power SYBR Green (Applied Biosystems) on a Viia7 system (Applied 
Biosystems). Target gene expression was determined by amplifying with the following 
primer pairs:  
Fmn1: F-GACGCCGCACCAACTTTATG,  
           R-GGCCTCTGACAGGGGTTTTT;  
GAPDH: F-GGTGAAGGTCGGTGTGAACG,  
                R-CTCGCTCCTGGAAGATGGTG;   
Gli1: F-CCCAGCTCGCTCCGCAAACA,  
         R-CTGCTGCGGCATGGCACTCT;      
Gremlin: F-ACTCGTCCACAGCGAAGAAC,  
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                R-TCATTGTGCTGAGCCTTGTC;  
Jag1: F-GTGCTACAATCGTGCCAGTG,  
          R-GGGGACCACAGACGTTAGAA;    
LacZ: F-GGGCCGCAAGAAAACTATCC,  
           R-TCTGACAATGGCAGATCCCA;  
Shh: F-TCTCGAGACCCAACTCCGAT,  
        R-GACTTGTCTCCGATCCCCAC; 
Nanog: F-AGGGTCTGCTACTGAGATGCTCTG,  
            R-CAACCACTGGTTTTTCTGCCACCG 
The GAPDH primers are widely used and the LacZ primers were previously 
described (Jeong et al., 2002). Unless specified otherwise, gene expression levels were 
normalized to GAPDH. 
 
5.5 TISSUE CULTURE AND CELL LINES 
NIH3T3 and HEK 293Tcells were cultured with 10% calf serum(CS) in DMEM. 
P19 cells were cultured wtih 2.5% fetal bovine serum (FBS) and 7.5% CS in α MEME 
(Sigma, #M8042). ES cell lines containing a Tamoxifen inducible Cre (CreER) and 
FLAG-tagged Gli1 or Gli3T (Vokes et al., 2007) were grown on MEF feeder cells. 
Expression of FLAG-tagged Gli1 and Gli3T was induced by adding 1mM 4OH-
Tamoxifen (Sigma, #H7904) for at least 48 hours. The feeder free J1 ES cells (ATCC, 
cat# SCRC 1010.) were cultured on gelatinized plates. All ES cells were cultured in 
media containing 15% FBS DMEM media with leukemia inhibitory factor (LIF) at final 




5.6 shRNA lentivirus infection  
1200ng of Nanog shRNA lentiviral plasmid (shNG; Sigma Mission RNAi # 
TRCN0000075333) or control (shCtrl; pLKO.1-puro vector containing 1.9Kb of inert 
DNA) was co-transfected with400ng of VSVG and 800ng of Δ8.9 into HEK293T cells in 
6-well plates using Lipofectamine 2000 (Life Technologies). After one day, the media 
was changed to ES cell media without LIF in order to obtain LIF-free supernatant for ES-
cell infection. After an additional 24 hours, the supernatant containing the viruses was 
harvested. Immediately before infection, the undiluted supernatant was mixed with 
polybrene (Sigma, #107689) to a final concentration of 4ug/ml and then mixed with 
5x105 of resuspended J1 ES cells (ATCC, Cat# SCRC 1010). The ES cells were then 
incubated overnight before providing fresh media (day 2). The ES cells were split day 
three into ES cell media containing 5 μg/ml puromycin and treated with 5 μM 
purmorphamine or 0.02% DMSO as control for 2 days. 
 
5.7 IMMUNOPRECIPITATION AND MASS SPECTROMETRY 
3x108 ES cells expressing FLAG-tagged GLI1/3R or control cells were harvested 
by using cell scrapers in cold DPBS. Cells were spun down at 300g for 5 min and 1 ml of 
Lysis buffer (20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 0.5M NaCl, 0.2% Triton X-100, 
10 mM KCl, 10% glycerol, add 0.5 mM DTT and Protease Inhibitor Cocktail Tablet, 
Roche) was per 0.3 ml of cell pellet. The cells were incubated with the lysis buffer at 4°C 
for 30min and spun down at 20000xg for 30min. 1 ml of supernatant was transferred into 
fresh tube and 0.3 volume of Buffer A (10 mM Hepes, pH7.9, 1.5 mM MgCl2, 10 mM 
KCl, 10% glycerol) was added to dilute the salt concentration of cell lysate to a final 
 68 
concentration of about 0.3M. 50ul of Anti-FLAG M2 Agarose (Sigma A2220) was mixed 
with 1.3 ml of cell lysate and rotated at 4°C for 2 hours then washed three times with 
Washing Buffer (10mM HEPES, pH 7.9, 1.5mM MgCl2, 300mM NaCl, 10mM KCl, 
0.2% TritonX-100, Complete Mini Protease Inhibitor Cocktail Tablet (Roche)) and then 
with Elution Base Buffer (10mM HEPES, pH7.9, 0.1M NaCl, 1.5mM MgCl2, 0.05% 
TritonX-100, Complete Mini Protease Inhibitor Cocktail Tablet (Roche), no FLAG 
peptides) once. The solution was spun down at 2500xg for 30sec. 30 ul of Complete 
Elution Buffer (200ug/ml 3xFLAG peptides, Sigma, #F4799 in Elution Base Buffer) was 
added and the mixture was incubated at 4°C for 30min. The supernatant was harvested by 
spinning at 2500xg for 30min. 20ul protein elutions were loaded on a 4-20% gradient 
SDS-PAGE gel (Biorad, #4561093) and minimally resolved by electrophoresis for 10 
minute at 120V. The gel was subsequently stained with Coomassie Blue for 1 hour and 
destained for 30 minuntes. The stained part of gel containing proteins was excised and 
proteins were digested with trypsin in gel. Peptides were sequenced on a liquid 
chromatography tandem mass spectrometry (LC-MS). Peptide identification was 
performed using Scaffold software.  
 
5.8 WESTERN BLOTS 
Protein samples were resolved by 9% SDS-PAGE and transferred onto 
nitrocellulose membranes (GE Healthcare, #10402468). Membranes were blocked with 
10% non-fat milk in TBST buffer for 30min and incubated with primary antibodies: anti-
FLAG antibody (Sigma, FLAG M2 antibody, F1804,1:4000), anti-HA (Thermo 
Scientific, 26183, 1:4000), anti-Nanog (Calbiochem, SC1000,1:2000), anti-Actin (Sigma, 
A2066, 1:2000), anti-OCT4 (Santa Cruz, SC5279,1:1000), in 3% non-fat milk at 4°C 
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overnight. After washing with TBST for 5min, membranes were then incubated with 
secondary antibodies: HRP-conjugated Rabbit-anti-Mouse secondary antibody (Jackson 
ImmunoResearch, 1:5000), HRP-conjugated Donkey-anti-Rabbit secondary antibody 
(Jackson ImmunoResearch, 1:5000), at room temperature for 1 hour. After washing with 
TBST three times, membranes were developed by using ECL Prime Western Blotting 
Detection Reagent (GE Healthcare, #RPN2232) and visualized by exposure to CL-
XPosure films (Thermo Scientific, #34091). 
 
5.9 LUCIFERASE ASSAY 
NIH3T3 cells or P19 cells were seeded at 0.5x105/well in 24-well plates and co-
transfected using Lipofectamine 2000 (Life Technologies, #11668019) with 300ng of 
luciferase reporter plasmid ptcΔ136-pGL3 (Nybakken et al., 2005), 100ng of pCIG-GLI1 
(Vokes et al., 2007), 200ng of pSV-β-galactosidase expression plasmid (Nybakken et al., 
2005), and 0-100ng NANOG expression constructs. For the Luciferase assay in NIH3T3 
cells, media was changed to 0.5% serum 24 hours after transfection. The cells were 
harvested and assayed for activity using the One-Glo Luciferase Assay Kit (Promega, 
#E6120). In P19 cells, the luciferase assay was performed 2 days after transfection. All 
luciferase activities were normalized with beta-galatcosidase activities by BetaFluor β-
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